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Giant dsDNA chloroviruses encode a diverse repertoire of glycosyltransferases 
(GTases) and methyltransferases (MTases) that biosynthesize unusual, methylated sugars 
independent of their host chlorella-like green algae prompting a reexamination of 
glycobiology systems. Unlike most other viruses, the prototype chlorovirus PBCV-1 
encodes most, if not all, of the machinery required to glycosylate its major capsid protein 
(MCP). The structures of the four N-linked glycans do not resemble any other glycans in 
the three domains of life. Here, we investigated the potential involvement of chlorovirus-
encoded putative GTases and MTases in glycosylation of the viral MCP. First, we aimed 
to generate site-directed virus mutants by targeting associated viral genes. We tested 
transformation methods using cell wall-degrading enzymes, electroporation, SiC 
whiskers, cell-penetrating peptides, and Agrobacterium to generate GT-gene mutations in 
the chlorovirus CA-4B. We successfully delivered preassembled Cas9 protein-sgRNA 
ribonucleoproteins (RNPs) to macerozyme-treated NC64A cells that resulted in a 
frameshift mutation in the CA-4B-encoded gene 034r, a homolog of PBCV-1 GT gene 
a064r.  
Unable to duplicate these results, we shifted our focus to characterize PBCV-1-
encoded proteins involved in glycan synthesis. Here, we demonstrated that protein 
A064R has three functional domains: domain 1 is a β-L-rhamnosyltransferase, domain 2 
 
is an α-L-rhamnosyltransferase, and domain 3 is a MT that methylates the C-2 hydroxyl 
group of the terminal α-L-rhamnose unit (α-L-Rha). We also established that methylation 
of the C-3 hydroxyl group of the terminal α-L-Rha is achieved by A061L. Moreover, 
genetic and structural analyses indicate the protein coded by PBCV-1 gene a111/114r, 
conserved in all chloroviruses, is a GT with three putative domains: galactosyltransferase 
(domain 1), xylosyltransferase (domain 2), and fucosyltransferase (domain 3). Hydrolytic 
assays supported these predictions suggesting that A111/114R is likely responsible for 
the attachment of three of the five conserved residues of the core region of this complex 
glycan. These findings provide additional support that the chloroviruses do not use the 
canonical host ER-Golgi glycosylation pathway to glycosylate their glycoproteins; 
instead, they perform glycosylation independent of cellular organelles using virus-
encoded enzymes.
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INTRODUCTION AND BACKGROUND 
1.1. OVERVIEW 
This Ph.D. dissertation thesis will introduce chlorovirus-encoded enzymes 
involved in the manipulation of carbohydrates that has provided many interesting and 
unexpected findings and concepts to the scientific community over the past 40 years. The 
aims addressed are twofold. First, to develop a transformation system that supports the 
genetic modification of the large dsDNA chloroviruses that infect unicellular Chlorella-
like green microalgae. Specifically, to investigate the progression of chlorovirus 
glycosylation that takes place independent of its host cell’s biosynthetic machinery using 
CRISPR-Cas9 gene editing. And second, to identify chlorovirus-encoded putative 
glycosyltransferases (GTases) involved in the unique glycosylation of its major capsid 
protein (MCP). Investigations of these sugar-manipulating enzymes will provide the field 
of glycobiology with new discoveries and may ultimately answer the central question 
about what benefits these viruses have by maintaining their own glycosylation machinery 
through evolution. 
1.2. PHYCODNAVIRIDAE FAMILY 
Conservative estimates suggest there is somewhere between 100,000 to several 
million species of algae and that only approximately 40,000 have been identified [1]. 
Microalgae form the base of the marine food web and their photosynthetic activities 
provide an important carbon sink that influences the global carbon cycle and even 
climate. The Phycodnaviridae consists of a family of viruses that infect these globally 
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important players and comprise a genetically diverse [2], yet morphologically similar, 
family of large icosahedral viruses that infect marine or freshwater eukaryotic algae. 
These viruses have dsDNA genomes ranging from 160 to 560 kb containing up to ~550 
predicted protein-encoding genes (CDSs) [3]. Members of the Phycodnaviridae are 
currently grouped into six genera (named after the hosts they infect): Chlorovirus, 
Coccolithovirus, Prasinovirus, Prymnesiovirus, Phaeovirus and Raphidovirus. In the 
broader evolution picture, phylogenetic analyses of numerous chlorovirus genes indicate 
that the viruses most closely related to the chloroviruses are members of the 
prasinoviruses. This genus includes viruses that infect the smallest eukaryotic cell 
Ostreococcus, and related species in the class Mamiellophyceae [4]. However, the 
chloroviruses evolved mainly by gene duplications and losses of genes belonging to large 
paralogous families, whereas Micromonas and Ostreococcus phycodnaviruses derive 
most of their genetic novelties though horizontal gene transfers (HGT) [5, 6].  
The discovery of phycodnaviruses expanded viral diversity among higher plants 
given that plants typically are infected by small, plus-stranded RNA containing particles 
that only encode a few genes [7]. Their genomes exhibit diverse structures, some with 
large regions of noncoding sequence and others with regions of ssDNA. To date, there 
are more than 30 species in the Phycodnaviridae, divided among 6 genera, and several 
members have been sequenced [2]. The genome analyses have revealed more than 1000 
unique genes, with only 14 homologous genes in common among the three genera of 
phycodnaviruses sequenced to date [8]. Thus, their gene diversity far exceeds the number 
of so-called core genes. Not much is known about the replication of these viruses, but the 
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consequences of these infections on phytoplankton have global affects, including 
influencing geochemical cycling and weather patterns [9-11]. 
1.2.A. History of Giant Viruses 
The second half of the 20th century was the golden age of virus discovery and 
most of the 2,000 recognized species of animal, plant, and bacterial viruses were 
discovered during these years [12]. Nevertheless, it wasn’t until the onset of a new 
century that introduced new infectious agents, enormous by comparison, that would 
challenge our previous guidelines that defined a virus. Their hallmark characteristics, 
namely their small size, tiny genomes and parasitic dependence on cellular hosts for 
replication, set them apart from all other living things despite their animation. However, 
with the onset of giant virus discovery, new descriptions of viruses have straddled life 
and nonlife, a divide that usually isn’t difficult to navigate. The discovery of giant viruses 
infecting protists pioneered by the isolation of Acanthamoeba polyphaga mimivirus 
(APMV), is one of the most unexpected and spectacular breakthroughs in virology in 
decades [13-17]. The giant viruses shatter the textbook definition of viruses as 
“filterable” infectious agents because their virions do not pass bacterial filters and 
obliterate all boundaries between viruses and cellular life forms in terms of size and 
number of genes. Indeed, not only are the particles of giant viruses larger than the cells of 
numerous bacteria and archaea but also the genomes of pandoraviruses, the current 
record holders at approximately 2.5 Mb [18], are larger and more diverse in gene content 
than many bacterial and archaeal genomes, from both parasites and free-living microbes 
[19]. The recently identified pandoraviruses and pithoviruses [20] are not only observable 
under light microscope, but also possess a previously unseen, asymmetrical virion 
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structure. These observations highlight the realization that discovery of the extensive 
diversity of giant viruses is in its infancy. 
Viruses in the family Phycodnaviridae, including the chloroviruses, are proposed 
to have an ancient, common evolutionary ancestry with some other large dsDNA viruses 
in the Poxviridae, Iridoviridae, Ascoviridae, Asfarviridae, Mimiviridae, Marseillivirdae, 
and Pithoviridae virus families. However, many more large DNA viruses are rapidly 
being discovered including pandoraviruses, faustoviruses, mollivirus, kaumoebavirus, 
cetratvirus, pacmanvirus, and orpheovirus [21] and the evolutionary relationships among 
these viruses is just starting to be analyzed [22-24]. Collectively, these giant viruses are 
referred to as nucleocytoplasmic large dsDNA viruses (NCLDVs) [22, 25-27] and it has 
been proposed that all these viruses should be included in a new order named 
Megavirales [28]. Diverse eukaryotes, such as protozoa, vertebrate animals, and insects, 
host these viruses. As their name suggests, NCLDVs replicate in both the nucleus and 
cytoplasm (phycodnaviruses, asfarvavirus, and iridovirus), or only within the cytoplasm 
(poxviruses). They possess large genomes (100 kb to up to 2.77 Mb) and a diverse gene 
repertoire that encodes up to 2556 predicted proteins [18]. To put the size of these large 
viral genomes into perspective, the smallest free-living bacterium, Mycoplasma 
genitalium, encodes 470 proteins [29]. Indeed, their genomes appear somehow closer in 
size to a typical cell than any other described virus, encoding proteins that have never 
been previously identified in viruses but have closely related eukaryotic homologs. 
Although the low levels of genetic similarity among NCLDVs complicate the 
precise phylogenetic placement of giant viruses, the relationships between NCLDV 
families have been reconstructed using multiple conserved genes [24]. Using five genes 
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that are nearly universal in the NCLDVs, a phylogenetic tree indicates that the NCLDVs 
form three major branches, with the Phycodnaviridae forming one branch along with the 
Mimiviridae and the pandoraviruses [22, 23]. Despite 93% of pandoravirus genes being 
previously unknown to biologists [18], the phylogenetic relationships of DNA 
polymerase genes from NCLDVs confidently places pandoraviruses with the family 
Phycodnaviridae, with an apparent specific affinity with coccolithoviruses like Emiliana 
huxleyi virus (Figure 1.1). Therefore, pandoraviruses and phycodnaviruses appear to be 
related and  phylogenetically distinct from the rest of the giant viruses. Also residing here 
in the same ancestral branch is another genus of phycodnaviruses, chloroviruses, that are 
the prime focus of this thesis. Although a common evolutionary ancestry of NCLDVs is 
generally accepted for at least some of the viruses considered to be NCLDVs, 









Figure 1.1. Maximum likelihood tree of DNA polymerase with genome length and 
virion size of various NCLDVs. The maximum likelihood tree shown is a simplified 
version of the NCLDV subtree for DNA polymerase adapted from [30], where collapsed 
clades in the original tree are represented by single branches. Numbers at each node are 
expected likelihood weights from 1,000 rearrangements. The scale throughout the figure 
is approximate. Figure from [31]. 
 
1.2.B. Chlorovirus Discovery 
Reports of virus-like particles (VLPs) in at least 44 taxa of eukaryotic algae have 
appeared between the early 1970s and 1991 [32]. These include incidental observations 
of VLPs in electron micrographs, for example the first description of VLPs in E. 
huxleyi was reported in 1974 [33]. Although these investigators did not publish an 
electron micrograph showing VLPs in E. huxleyi, they mentioned that VLPs 
in Chrysochromulina mantoniae resembled those of VLPs commonly found in moribund 
or dead Coccolithus huxleyi cells (now referred to as E. huxleyi). It was not until 1979 
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that a phycodnavirus was even isolated; the virus infected the marine unicellular 
alga Micromonas pusilla [34]. However, this report was largely ignored until the early 
1990s [35] when high concentrations of viruses in aquatic environments were being 
described [36]. These early observations were not further pursued by virologists for 
several reasons that include: (i) evidence for the presence of viruses in algae was solely 
microscopic and many times it corresponded to a single observation; (ii) in some cases, 
algae were field-collected and they were no longer available for study; (iii) cultures were 
not axenic; (iv) technical problems regarding virus isolation (e.g., low concentration); (v) 
the inability to culture the host [37].  
In 1978, Kawakami and Kawakami [38] described VLPs in Chlorella isolated 
from the protozoan Paramecium bursaria. However, the virus particles were neither 
isolated nor characterized. In the early 1980s, a series of landmark discoveries were made 
by Van Etten and Meints [39-42] when they characterized a large virus with polyhedron 
structure present in the isolated symbiotic alga Chlorella isolated from Hydra viridis. 
They reported that the virus lysed the whole algal population in 24 h and virus particles 
were absent in endosymbiotic Chlorella. Further characterization determined that the 
virus possessed a 250 kb dsDNA with at least 19 structural proteins, including a 46 kDa 
major capsid protein (MCP). Six other hydra Chlorella viruses were isolated within a 
short time. Initial restriction fragment analysis of all the viruses that infected 
endosymbiotic Chlorella (now referred to as chloroviruses) revealed four different types 
of isolates and showed no correlation between genomic composition and geographical 
origin of the viruses. 
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One of the six genera in the Phycodnaviridae, chloroviruses are icosahedral-
shaped dsDNA-containing viruses that infect and replicate in certain strains of 
unicellular, symbiotic, chlorella-like green algae. Chloroviruses are widespread 
in freshwater environments in all parts of the globe and have been isolated from 
freshwater sources in Europe, Asia, Australia, as well as North and South America [43]. 
Chlorovirus titers are variable by season and location, but typically fluctuate between 1 
and 100 PFU/mL, although high abundances of up to 100,000 PFU/mL may occur in 
some environments. Due to the rich genetic diversity and high specialization of 
individual species with respect to infectious range, variations in their ecology are not 
unusual, resulting in unique spatio-temporal patterns, which ultimately depend on 
lifestyle and nature of the host. As such, titers fluctuate during the year with the highest 
titers typically occurring in the spring, followed by another increase in the late fall while 
in mid-summer there can be few detectable viruses in the water column [44]. Chlorovirus 
genome sequences have also been detected in metagenomes from marine environments 
[45] but no chloroviruses have been isolated from these environments.  
Known chlorovirus hosts, which are normally mutualistic endosymbionts and are 
often referred to as zoochlorellae [46], are associated with the ciliate protozoan 
Paramecium bursaria (Figure 1.2a) [38], the coelenterate Hydra viridis [39, 40], or the 
heliozoon Acanthocystis turfacea [47]. Four such zoochlorellae and their viruses 
are Chlorella variabilis NC64A (NC64A) and its viruses (referred to as NC64A 
viruses), Chlorella variabilis Syngen 2–3 and its viruses (referred to as Osy 
viruses), Chlorella heliozoae SAG 3.83 and its viruses (referred to as SAG viruses) 
and Micractinium conductrix Pbi and its viruses (referred to as Pbi viruses). The 
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zoochlorellae are resistant to virus infection when they are in their symbiotic relationship, 
because the viruses have no way of reaching their hosts. For example, the zoochlorellae 
NC64A lives inside the ciliate P. bursaria in a special perialgal vacuole (Figure 1.2b) that 
is surrounded by a host-derived membrane, which protects them from attack by host lytic 
enzymes. While an individual protist can harbor up to several hundred algal cells at any 
given time, free-floating algae are highly susceptible to chloroviruses, indicating that 
such endosymbiosis serves to provide resistance from infection. In this relationship, P. 
bursaria can produce glutamine and Mg2+ for the symbiotic algae, and the algae can take 
glutamine as a nitrogen source and utilize Mg2+ for chlorophyll-based photosynthesis 
[48]. In return, symbiotic algae may provide photosynthetic products, such as fructose, 
maltose, and oxygen, to host cells. Previous studies also demonstrate existing nutrient 








Figure 1.2. Light and transmission electron micrographs of P. bursaria with 
endosymbiotic chlorella. (a) Differential interference contrast (DIC); (b) Transmission 
electron microscopy (TEM); Ma, macronucleus; OA, oral apparatus; Chl, chlorophyll; 
PV, perialgal vacuole membrane; CW, cell wall; Mt, mitochondrion; Tc, trichocyst. 
Figure from [50]. 
 
A phylogenetic analysis of 32 concatenated conserved genes from 41 
chloroviruses that infect three zoochlorellae hosts, i.e., 14 NC64A viruses, 14 Pbi viruses, 
and 13 SAG viruses, revealed three important features about chlorovirus evolution 
(Figure 1.3a): (i) viruses infecting the same zoochlorella host clustered in monophyletic 
clades despite being isolated in diverse locations across five continents; (ii) The 
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branching pattern of the three main virus clades does not match the phylogeny of the 18S 
RNA alignment of their zoochlorellae hosts (Figure 1.3b), which eliminates the simplest 
co-evolution scenario whereby the algae and virus lineages separated at the same time; 
(iii) The phylogenetic position of virus NE-JV-1 within the Pbi virus clade is the first 
representative of a previously unknown subgroup of chloroviruses. The most recently 
discovered chlorovirus group, the Osy viruses, are interesting because phylogenetic 
analysis of 29 proteins encoded by the 32 conserved concatenated core genes of 
chlorovirus Osy-NE5 indicates that this virus resides between two separate phylogenetic 




Figure 1.3. Phylogenies of chloroviruses and algal hosts. (a) Phylogenetic tree shows 
the evolutionary relationships between 47 chloroviruses based on amino acid sequences 
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encoded by 32 conserved concatenated genes. The Maximum Likelihood tree was 
constructed using the MEGA 6.0 software with the Maximum Likelihood algorithm and 
default setting. The bar length represents 0.2 substitutions per amino acid site. A recently 
characterized Osy chlorovirus species resides between separate phylogenetic subclades of 
NC64A viruses (not included); Four Ostreococcus virus sequences served as outgroups to 
root the tree. (b) Maximum Likelihood tree of three algal hosts based on 18S RNA 
alignment. Figure from [52].  
 
Large amounts of chloroviruses can be produced and assayed by plaque formation 
on lawns of algae using standard bacteriophage techniques. This provides a sensitive 
bioassay that is still used today. Attempts to culture the zoochlorellae from hydra to serve 
as a host for the viruses that infect hydra zoochlorellae were unsuccessful [37]. Given 
Chlorella can be grown independently of their symbiotic partners in the laboratory, 
permitting plaque assay of the viruses and synchronous infection of their hosts, NC64A 
virus Paramecium bursaria chlorella virus-1 (PBCV-1) naturally become the prototype 
virus in the laboratory allowing one to study the life cycle of chloroviruses in detail. 
Extending behind virological orthodoxy, the chloroviruses, especially PBCV-1 and its 
host NC64A, are serving as a flexible model system to address concepts of co-evolution 
at the phenotypic and genotypic levels, ecological dynamics, and predator-prey modeling 
[53-55].  
1.2.C. Prototype chlorovirus Paramecium bursaria chlorella virus-1 
Several hundred plaque-forming chloroviruses have been characterized to various 
degrees. The genomes of 43 chloroviruses infecting four different alga hosts have been 
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sequenced, assembled and annotated [51, 52, 56-59]. Collectively, the viruses encode 
genes from 643 predicted protein families; however, any given chlorovirus only has 330 
to 416 protein-encoding genes. Thus, the genetic diversity among these viruses is large, 
and many of the proteins are unexpected for a virus. With the exception of homologs 
solely in other chlorovirus members, about 50% of their protein-encoding genes do not 
match anything in the databases. Given the coding capacity of the chloroviruses, it is not 
surprising that they encode many unusual proteins. Some of these viruses also have 
introns and inteins, which are rare in viruses. The most studied chlorovirus and the first 
phycodnavirus to be sequenced was PBCV-1 which infects NC64A [60]. The C. 
variabilis 46.2 Mb genome was sequenced [61] and the availability of both host and virus 
sequences makes chloroviruses an attractive model system. 
Cryo-electron microscopy (cryo-EM) and six-fold symmetry averaging three-
dimensional reconstruction of PBCV-1 virions at ~26 Å resolution indicated that the 
capsid was an icosahedron that is 1900 Å in diameter from point-to-point with a 
triangulation number of 169d [62]. The capsid covers a single lipid bi-layered envelope, 
which is required for infection [63, 64]. The trimeric capsomers are arranged into 20 
triangular facets (trisymmetrons, each containing 66 capsomers) and 12 pentagonal facets 
(pentasymmetrons, each containing 30 trimers and one pentamer at each of the 
icosahedral vertices) (Figure 1.4a). However, as cryo-EM procedures have improved, 
more details have emerged about the structure of the PBCV-1 virion; the virus is much 






Figure 1.4. Cryo-EM structure of PBCV-1. (a) Hexagonal arrays of major capsomers 
form trisymmetrons and pentasymmetrons. The unique vertex with its spike structure is at 
the top. Capsomers in neighboring trisymmetrons are related by a 60 rotation, giving rise 
to the boundary between trisymmetrons. A fiber extends from one of the capsomers in 
each of the trisymmetrons. (b) The cryo-EM density (3.5 Å resolution) of PBCV-1 after 
removing the MCP so that 14 minor capsid proteins are visible. Each protein is shown in 
a different color. (c) Cross section of a five-fold averaged cryo-EM image of PBCV-1 
reveals a long narrow cylindrical spike structure at one vertex and the viral internal 
membrane (green) surrounding the viral genome asymmetrically (left). Cross section of a 
five-fold averaged cryo-EM image of PBCV-1 as the virus is ready to release its DNA 
into the host cell (right). (a) is from [63], (b) is from [65], and (c) is from the cover of J. 
Virology issue 17, 2012. 
 
Improvement to 8.5 Å resolution and five-fold symmetry 3D reconstruction of 
cryo-EM images revealed that one PBCV-1 vertex has a 560 Å long spike-structure 
(Figure 1.4a); 340 Å extends from the surface of the virus [63, 64]. The part of the spike 
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structure outside the capsid has an external diameter of 35 Å at the tip, expanding to 70 Å 
at the base. The spike structure widens to 160 Å inside the capsid and forms a closed 
cavity inside a large pocket between the capsid and the membrane enclosing the virus 
DNA (Figure 1.4c). Therefore, the internal virus membrane departs from icosahedral 
symmetry adjacent to the unique vertex (Figure 1.4c). Consequently, the virus DNA is 
packaged non-uniformly in the particle. (This asymmetric packaging of the genome was 
reported previously in an ultra-structural study of the Pbi virus CVG-1 [66] and is 
apparent in other earlier electron microscopy studies). External “fibers” extend from 
some of the trisymmetron capsomers (one per trisymmetron) and are rigid enough to be 
resolved with cryo-EM methods; the fibers presumably aid in virus attachment to the host 
(Figure 1.4a). The fiber-containing capsomer is always located in the middle of the 
second row of capsomers in the trisymmetron. 
Recently, a 3.5 Å near-atomic resolution structure of PBCV-1 by cryo-EM was 
reported [65]. This resolution was accomplished by correcting for the Ewald sphere effect 
in single cryo-EM reconstructions [67]. Otherwise, the technology was stalled at ~4.5 Å 
resolution. The 3.5 Å resolution led to the identification of 14 virus-encoded, minor 
capsid proteins that form a hexagonal network below the outer capsid shell, stabilizing 
the capsid by binding neighboring capsomers together (Figure 1.4b). This minor capsid 
protein shell cements most of the gaps between neighboring capsomers and uses 
transmembrane helices to mediate inner viral membrane association. The size of the viral 
capsid is determined by a “tape-measure” minor capsid protein of which there are 60 
copies in the virion. Homologs of the tape-measure protein and some of the other minor 
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capsid proteins exist in other NCLDVs. Thus, a similar capsid assembly pathway might 
be used by other NCLDVs. 
The PBCV-1 genome is a linear ~331-kb, dsDNA molecule with 35 nucleotide-
long, covalently closed hairpin termini that exist in one of two forms. The two forms are 
complementary when the 35-nucleotide sequences are inverted [68]. Identical ~2.2-kb 
inverted repeats flank each hairpin end [69]. The remainder of the PBCV-1 genome 
contains primarily single-copy DNA. The GC content of the PBCV-1 genome is ~40%; 
by contrast, its host nuclear genome is ~67% GC. The PBCV-1 genome was re-
sequenced in 2012 to correct mistakes in the original sequence that was reported in the 
mid-1990s [60]. Using 40 codons as the minimum CDS size and avoiding large overlaps, 
PBCV-1 contains 416 CDSs (three outermost rings in Figure 1.5). Of the predicted CDSs, 
~50% resemble proteins of known function, including many that are novel for a virus. 
The CDSs are evenly distributed on both DNA strands with minimal intergenic spaces. 
One exception is a 1,788-nucleotide sequence in the middle of the PBCV-1 genome 
encoding 11 tRNAs, which is co-transcribed as a large precursor and then processed to 




Figure 1.5. Mapping of the PBCV-1 transcriptome. PBCV-1 genes on the forward and 
reverse strands are depicted by red and blue boxes respectively. The green curves in the 
interior concentric circles represent the normalized read coverage for each time point (7, 
14, 20, 40, and 60 min p.i.) of the experiment in logarithmic scale (base 10). Open boxes 
are superimposed onto the read coverage curves to show calculated MRPN values for 
each gene. Below the outer circle, red and green triangles indicate the location of 
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predicted splice events and polyadenylation cleavage site, respectively. Note: the PBCV-
1 genome is a linear molecule with inverted repeats and closed hairpin ends that is 
depicted as a circle. The two ends are at the 12 o’clock position. Figure from [71]. 
 
PBCV-1 and the other chlorovirus genomes contain methylated bases, which 
occur in specific DNA sequences [72]. Genomes from 37 chloroviruses have 5-
methylcytosine (5mC) in amounts ranging from 0.12 to 47.5% of the total cytosines. In 
addition, 24 of the 37 viral DNAs contain N6-methyladenine (6mA) in amounts ranging 
from 1.5 to 37% of the total adenines [32]. The methylated bases occur in specific DNA 
sequences, which led to the discovery that chloroviruses encode multiple 5mC and 6mA 
DNA methyltransferases (MTases). Interestingly, the methylated bases are part of the 
virus-encoded DNA restriction and DNA modification systems [73]. About 25% of the 
virus-encoded DNA MTases have companion DNA site-specific (restriction) 
endonucleases, including some with unique cleavage specificities (2 to 4 bp) that are sold 
commercially [74, 75]. Prior to the discovery that the chloroviruses encoded enzymes 
with DNA restriction endonuclease activity, all known DNA restriction endonucleases 
were from bacteria. The purpose of the other virus-encoded DNA MTases is unknown. 
One possibility is that they were originally associated with companion DNA  
restriction endonucleases that have subsequently been lost in evolution or serve some 
other unknown physiological function. 
The sum total of chlorovirus-encoded CDSs from 45 analyzed viruses (NC64A, 
Pbi, SAG viruses) include ~650 protein families. Any one virus encodes no more than 
~400 CDSs, thus the chloroviruses have a lot of genetic diversity. Furthermore, some 
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chlorovirus-encoded CDSs have as many as three distinct functional domains, and each 
domain encodes an independent enzyme activity. Therefore, the genetic diversity of the 
chloroviruses is much larger than the total number of genes. Why chloroviruses need this 
large amount of gene diversity and the origins of many of these genes is unknown.  
Three-dimensional reconstruction of PBCV-1 in the presence of NC64A cell 
walls supports the hypothesis that the virus spike structure first contacts the cell wall 
(Figure 1.4c) [76] and that fibers appear to aid in holding the virus to the wall. The 
PBCV-1 protein A140/145R, referred to as Vp130, was reported to be involved in 
recognizing the host receptor [77] and to be located at a unique vertex [78]. The virus 
spike structure is too narrow to deliver DNA into the host and likely serves to puncture 
the wall using a virus-associated enzyme(s) (Figure 1.6a) before it is pushed aside. 
PBCV-1 attachment to its host receptor is rapid and specific with an adsorption rate of 5 
× 10−9/mL/min [79]. The early stages of PBCV-1 attachment are reversible [80]. The 
inability to attach to non-host cells is a major factor in limiting chloroviruses’ host range. 
The identity of the host receptor, which is uniformly present over the entire surface of the 







Figure 1.6. Proposed replication cycle of PBCV-1 (top) and infection timeline 
(bottom). Attachment of PBCV-1 to the algal wall and digestion of the wall at the point 
of attachment (a). STEM tomograph showing the close proximity between the viral and 
host internal membrane forming a membrane-lined tunnel between the virus and its host 
(b). The viral DNA moves to the nucleus where early gene transcription begins at 5 to 10 
min p.i. Early mRNAs move to the cytoplasm for translation, and at least some early 
proteins presumably return to the viral genome located at or near to the nucleus to initiate 
viral DNA replication, which begins ~60 p.i., followed by late gene transcription. Late 
mRNAs move to the cytoplasm for translation and many of these late proteins are 
targeted to the virus assembly centers (c), where virus capsids are formed, and DNA is 
packaged. Mature infectious virus particles virus particles appear in the cytoplasm of the 
cell ~45 min prior to virus release. The Chlorella cell membrane and wall lyses (d), and 
infectious PBCV-1 progeny viruses are released at 6 to 8 h p.i. (→) Known events; (- ->) 
hypothesized events. EM micrographs by Kit Lee. Figure adapted from [82, 83]. 
 
PBCV-1 encodes five proteins that degrade potential cell wall polysaccharides 
including two chitinases [84], a chitosanase [84], a β-1,3 glucanase [85], and an alginate 
lyase-like enzyme [86-88]. Following host cell wall degradation, the virus internal 
membrane fuses with the host membrane (Figure 1.6b), forming a membrane-lined tunnel 
between the virus and its host [83], leaving an empty capsid attached to the surface. The 
virus-host membrane fusion process triggers rapid depolarization of the host plasma 
membrane resulting in the release of K+ from the cell, presumably initiated by a virus 
encoded K+ channel that is located in the virus internal membrane [89]. The 
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depolarization of the host’s cell membrane is also thought to prevent secondary infection 
from another virus or secondary transporters. The rapid loss of K+ from the host and 
associated water fluxes significantly reduce the host turgor pressure, which aids ejection 
of viral DNA and virion-associated proteins into the host (Figure 1.6b) [90].  
Circumstantial evidence plus microscopic images [83] indicates that the viral 
DNA and suspected DNA-associated proteins quickly move to the nucleus taking swift 
command of the host transcription machinery. Given none of the chloroviruses encode a 
recognizable DNA-dependent RNA polymerase (DdRp) gene, its rapid transit to the host 
nucleus supports these observations. RNAseq experiments revealed that ~50 PBCV-1 
genes are expressed within the first 7 min p.i. [71]. By 60 min p.i., essentially all of the 
PBCV-1 genes are expressed at some level and ~40% of the poly (A+) containing RNAs 
in the infected cell are PBCV-1 transcripts. This rapid increase in viral mRNAs probably 
involves increased viral transcription together with the selective degradation of host 
mRNAs within 5 min p.i., presumably by the PBCV-1 encoded and packaged DNA 
restriction endonucleases. Further, host chromatin remodeling is probably involved 
because PBCV-1 also encodes and packages an enzyme (referred to as vSET) that tri-
methylates Lys-27 in histone 3 [91] which likely suppresses host transcription. Not 
surprisingly, transcription of host genes is altered within the first 7 min after PBCV-1 
infection [92]. This reversal in transcription control from host to virus implies that some 
component(s) must facilitate active transport of the virus genome to the nucleus. 
Presumably virus DNA synthesis begins in the nucleus before moving to the 
cytoplasm. By 4 h p.i., the amount of virus DNA in the cell is at least four times higher 
than the DNA in the cells at the time of virus infection. At 3 to 4 h p.i., assembly of 
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PBCV-1 capsomers begins in localized regions of the cytoplasm, which become 
prominent 4 to 5 h p.i. (Figure 1.6c). These localized regions, called virus assembly 
centers or virus factories, consist of host cisternae that are derived from the ER next to 
the nuclear membrane [93]. By 5 to 6 h p.i. infectious PBCV-1 progeny accumulates in 
the cytoplasm and localized lysis of the host cell membrane and cell wall releases 
progeny at 6 to 8 h p.i. (Figure 1.6d). Each infected algal cell releases up to ~1000 
particles, of which ~25% form plaques. Mechanical disruption of cells releases infectious 
virus particles 30 to 50 min prior to cell lysis, indicating the virus is mature in the cell 
and that it does not acquire its glycoprotein capsid by budding through the host plasma 
membrane as it is released from the cell [94]. Currently nothing is known about the clock 
mechanism that must operate to time the release of the nascent virions; however, the 
viruses encode several cell wall-degrading enzymes that presumably function for the 
virus to escape the cell. A schematic diagram of the predicted PBCV-1 replication cycle 
is reported in Figure 6. 
1.3. CARBOHYDRATE MANIPULATING GENES IN CHLOROVIRUSES 
  Chloroviruses are unusual because they encode enzymes involved in 
manipulating carbohydrates [95-97]. These include enzymes involved in making 
extracellular polysaccharides, such as hyaluronan and chitin, enzymes that make 
nucleotide sugars, such as GDP-L-fucose (GDP-L-Fuc) and GDP-D-rhamnose (GDP-D-
Rha) and enzymes involved in the synthesis of glycans attached to the virus MCPs. This 
latter process differs from that of all other glycoprotein containing viruses that 
traditionally use the host endoplasmic reticulum (ER) and Golgi machinery to synthesize 
and transfer the glycans. Van Etten et al. (2017) [97] listed putative chlorovirus genes 
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involved in carbohydrate metabolism, which are encoded by the 43 chloroviruses whose 
genomes have been sequenced, in Tables 1.1-1.3. Recombinant proteins have been 
produced from some of these genes, and the proteins have been characterized (indicated 
in bold in the tables). When some of the genes were initially cloned and the recombinant 
proteins characterized, the genes were hybridized to many other chlorovirus genomes by 



















Table 1.1.  
Chlorovirus encoded enzymes involved in the synthesis of polysaccharides 
      
1 Hyaluronan synthase; 2 chitin synthase; 3 chitin binding proteins, except for the chitinase 
proteins involved in degrading polysaccharides; a the recombinant protein has the 
predicted activity. The numbers refer to the protein names, and the R and L refer to the 










1.3.A. Polysaccharide Synthesizing Enzymes  
Three PBCV-1-encoded enzymes, UDP-glucose dehydrogenase (UDP-GlcDH, 
gene a609l) [98], glutamine:fructose-6-phosphate amino transferase (GFAT, gene a100r) 
[98], and hyaluronan synthase (has gene) [99] contribute to the synthesis of hyaluronan 
(hyaluronic acid), a linear polysaccharide composed of alternating β-1,4-glucuronic acid 
(GlcA) and β-1,3-N-acetylglucosamine (GlcNAc) residues. UDP-GlcDH and GFAT are 
involved in the biosynthesis of hyaluronan precursors. Until the has gene (a098r) was 
discovered in PBCV-1, hyaluronan was only thought to occur in vertebrates and a few 
pathogenic bacteria, where it forms an extracellular capsule, presumably to avoid the 
immune system [100, 101]. Hyaluronan is an essential constituent of the extracellular 
matrix in vertebrates and consists of ~10,000 or more alternating GlcA and GlcNAc 
residues. Typically, the HAS enzyme is located on the inner surface of the plasma 
membrane. The newly-synthesized hyaluronan then moves through the membrane and 
cell wall to the extracellular matrix. The identification of these three genes, transcribed 
early in virus infection, led to the discovery that hyaluronan lyase-sensitive hair-like 
fibers begin to accumulate on the surface of PBCV-1-infected host cells by 15 min p.i. 
By 4 h PI, the infected cells are covered with a dense fibrous hyaluronan network [102].  
 The has gene is present in about 30% of the chloroviruses. Surprisingly, many 
chloroviruses that lack a has gene have a gene encoding a functional chitin synthase (chs) 
gene. Furthermore, cells infected with these viruses produce chitin fibers on their external 
surface [103]. Chitin, an insoluble linear homopolymer of β-1,4-linked GlcNAc residues, 
is a common component of insect exoskeletons, shells of crustaceans, and fungal cell 
walls. A few chloroviruses encode both chs and has genes and form both chitin and 
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hyaluronan on the surface of their infected cells [103, 104]. Finally, some chloroviruses 
lack both genes and cells infected with these viruses produce no known extracellular 
polysaccharides [102]. The fact that many chloroviruses encode enzymes involved in 
extracellular polysaccharide biosynthesis, which require huge amounts of ATP for their 
synthesis, suggests that the polysaccharides are important in the viral life cycles. 
However, they do not appear to be required for chlorovirus replication in the laboratory. 
Furthermore, because all of the chloroviruses, including ones that lack the has and chs 
genes, have been isolated from natural sources in recent years, the genes do not appear to 
be essential for replication in native environments. Currently, it is not known how or why 
the chloroviruses acquired these polysaccharide-synthesizing genes.  
1.3.B. Nucleotide Sugar Metabolism Enzymes  
Many chloroviruses also encode enzymes involved in nucleotide sugar 
metabolism, as well as other sugar metabolic enzymes (Table 1.2). Two enzymes 
involved in synthesizing GDP-L-Fuc are encoded by all of the NC64A, SAG and Syn 
chloroviruses, GDP-D-mannose (GDP-D-Man) 4,6 dehydratase (GMD) and GDP-4-keto-
6-deoxy-D-Man epimerase reductase (GMER, also referred to as Fuc synthase) (Table 
1.2), comprise a highly-conserved three-step pathway in bacteria, plants and animals that 
converts GDP-D-Man to GDP-L-Fuc [105]. In vitro reconstruction of the pathway using 
recombinant PBCV-1 GMD and GMER proteins resulted in the synthesis of GDP-L-Fuc 
as expected. Unexpectantly, PBCV-1 GMD is unusual because it can also convert the 
GMD product into GDP-D-Rha in the presence of NADPH, that is, the enzyme performs 
two activities that produces both sugars inside the infected cell [105]. Interestingly, the 
chlorovirus ATCV-1 GMD homolog lacks the GDP-Rha forming activity [106]. Both 
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Fuc and Rha are in the glycans attached to the PBCV-1 MCP. The Pbi chloroviruses lack 
both gmd and gmer genes even though the glycans attached to the MCP from the three 
evaluated Pbi viruses have Fuc [107]. Other chloroviruses encode additional sugar 
metabolizing enzymes including a UDP-D-Glc-4,6-dehydratase [108] and a putative 
Man-6-phosphate isomerase.  
Besides the chlorovirus-encoded enzymes described above, the viruses have four 
additional genes predicted to encode enzymes involved in sugar metabolism (Table 1.2). 
Recombinant proteins have not been produced from any of these genes, and so, it is 
unknown if they encode functional enzymes. These putative enzymes include an 
acetyltransferase (AT) encoded by all 43 chloroviruses, a D-lactate dehydrogenase (D-
LD) encoded by 32 chloroviruses, fumarate reductase (FRD) encoded by five 
chloroviruses and ADP-ribosyl glycohydrolase (ADP-RGH) encoded by nine 
chloroviruses, all but two of which are Pbi viruses. The roles these putative enzymes play 
in the viral life cycles are unknown.  
1.3.C. Unusual Attachment of Glycans to the Chlorovirus Major Capsid Proteins  
 Structural proteins of many viruses, such as rhabdoviruses, herpesviruses, 
poxviruses and paramyxoviruses, are glycosylated. Glycans contribute to the protease 
resistance and the antigenicity of these viruses. Most virus glycans are linked to Asn in 
the protein via GlcNAc, although some viruses also have O-linked glycans attached to 
either Ser or Thr residues via an amino sugar, usually GlcNAc or N-acetylgalactosamine 
(GalNAc). Typically, viruses use host-encoded GTases and glycosidases located in the 
ER and Golgi apparatus to add and remove N-linked sugar residues from virus 
glycoproteins either co-translationally or shortly after translation of the protein. The virus 
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glycoproteins are then transported to the host plasma-membrane where progeny viruses 
bud though the membrane and they only become infectious as they leave the cell [109]. 
However, unlike the process described above, glycosylation of the chlorovirus MCPs 
differs from that scenario because the viruses encode most, if not all, of the machinery for 
the process. Furthermore, the glycosylation process occurs in the cytoplasm [96, 97]. 
  The conclusion that the chlorovirus PBCV-1 MCP (Vp54, gene a430l) is 
glycosylated by a different mechanism than that used by other characterized viruses 
originally arose from antibody studies [110]. Rabbit polyclonal antiserum [111] particles 
inhibited virus plaque formation by agglutinating the virions. Spontaneously derived 
antiserum-resistant, plaque-forming variants of PBCV-1 occur at a frequency of 10−5 to 
10−6. Originally, four serologically distinct classes were identified plus wild type virus; 
subsequently two additional antigenic variants have been isolated for a total of six 
antigenic variants. Polyclonal antisera prepared against members of each of these 
antigenic classes react predominately with the Vp54 protein equivalents from the viruses 
in the class used for the immunization. Each of the Vp54 proteins from the antigenic 
variants migrated faster on SDS-PAGE than those from the strains from which they were 
derived, indicating a lower molecular weight. However, all of the de-glycosylated MCPs 
migrated at the same rate on SDS-PAGE, indicating that the size differences were due to 
the attached glycans. In addition, the a430l nucleotide sequence in each of the antigenic 
variants was identical to the wild-type gene; these results verified that the polypeptide 
portion of Vp54 was not altered in the antigenic variants. Western blot analyses of Vp54 
proteins before and after removing the glycans with trifluoromethane-sulfonic acid or 
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altering the glycan with periodic acid, also supported the notion that the antigenic 
variants reflected differences in the Vp54 glycans, not the Vp54 polypeptide [110]. 
Additional observations supported the concept that PBCV-1 Vp54 glycosylation 
was unusual: (1) unlike viruses that acquire their glycoproteins(s) by budding through a 
plasma membrane, which results in infectious particles, plaque-forming PBCV-1 
particles accumulate inside the host 30–40 min before virus release [112]; (2) all of the 
antigenic variants were grown in the same host so the glycan differences are not due to 
the host; (3) polyclonal antibodies to Vp54, the MCP, do not react with host 
glycoproteins; (4) the PBCV-1 Vp54 protein, like the PBCV-1 encoded GTases,  lacks an 
ER and Golgi signal peptide; (5) unlike most glycoproteins that exhibit size micro-
heterogeneity, PBCV-1 Vp54 appears homogeneous on SDS-PAGE; in addition, mass 
spectrometry analysis only revealed one satellite peak that differed from the main peak 
by 140 Da, the approximate weight of either one arabinose (Ara) or xylose (Xyl) residue 
[113]; and (6) the ability to easily crystallize Vp54 as a homotrimer provided additional 
evidence that the protein is essentially homogeneous [114, 115].  
Evidence that the N-linked Vp54 glycans are not attached to the Vp54 protein by 
a N-linkage was initially obtained from the X-ray crystal structure of the protein [115]. 
The structure revealed that the protein had four N-linked glycans at Asn positions 280, 
302, 399 and 406 [114]. None of these Asn were located in an Asn-X-(Thr/Ser) sequon 
sequence commonly recognized by ER located GTases [116]. This finding also explained 
why prior attempts to remove Vp54 glycans with enzymes that cleave traditional N-
linked glycans were unsuccessful. Nandhagopal et al. [114] also reported that Vp54 
contained two O-linked glycans. However, re-examination of the X-ray crystal data 
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(Figure 1.7) indicated that no O-linked glycans were present in the protein [115], which 




Figure 1.7. Structure of a PBCV-1 major capsid protein (Vp54) N-glycans. (a) Cryo-
EM close-up view of PBCV-1 trimers. Shaded-surface representations of the 
reconstructions viewed down an icosahedral three-fold axis (triangle). Bar, 100 Å. (b) 
Structure of a single PBCV-1 MCP (Vp54). The four glycans attached to the MCP at 
amino acids Asn 280 (green), Asn 302 (black), Asn 399 (red) and Asn 406 (blue) are on 
the outer surface of the virus. (c) Three of the MCPs are assembled into a capsomer, 
viewed from the top. (a) is from [62] and (b,c) are from [117]. 
 
1.3.D. Glycan Structures Attached to Chlorovirus Major Capsid Proteins   
 The structures of the PBCV-1 Vp54 N-linked glycans were reported recently, and 
they consist of 8–10 neutral monosaccharide residues, producing a total of four 
glycoforms (Figure 1.8) [115]. These structures do not resemble any structure previously 
reported in the three Domains of Life. Among their most distinctive features are: (1) the 
four glycoforms share a common core structure, and the four glycoforms are related to 
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the non-stoichiometric presence of two monosaccharides, L-Ara and D-Man; the most 
abundant glycoform consists of nine neutral monosaccharide residues organized in a 
highly‐branched fashion; (2) the glycans are attached to the protein by a β‐Glc linkage, 
which is rare in nature and has only been reported in glycoproteins from a few organisms 
[118-121]; and (3) the glycoform contains a dimethylated Rha as the capping residue of 
the main chain, a hyper-branched Fuc residue and two Rha residues with opposite 




Figure 1.8. Structures of PBCV-1 Vp54 N-glycans. Ara and Man are not stoichiometric 
substituents and create four different glycoforms. The two on the left are the most 
abundant, and both have Man. The structure at the bottom represents the conserved core 
oligosaccharide that is present in all of the chloroviruses studied to date. Residues within 
the box are those strictly conserved, while D-Rha (outside the box) is a semi-conserved 
element because its absolute configuration is virus dependent. Figure modified from [97]. 
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Attempts to fit the Vp54 glycan structures into the original Vp54 X‐ray crystal 
structure [114] were unsuccessful and led to a re‐examination of the original structure. 
This re‐examination produced a structure that was compatible with the four N-linked 
glycan structures (Figure 1.7b). As mentioned above, the revised structure lacks the two 
O-linked glycans reported originally.  
The PBCV-1 Vp54 has a molecular weight of 53,790 Da. The a430l gene encodes 
Vp54 with a predicted molecular weight of 48,165 Da so the combined sugars have a 
molecular weight of 5625 Da, which is about the weight of the four glycans. Vp54 was 
also reported to have a myristic acid attached to the carboxyl portion of the protein [122]. 
However, myristic acid has not been observed in any of the recent Vp54 structural 
experiments, and so, its status is currently unknown. The structures of the Vp54 glycans 
from the PBCV-1 antigenic variants, referred to above, are currently being determined, 
and as expected, the structures are truncated forms of the wild-type PBCV-1 glycans. 
PBCV-1 particles were reported to have two additional glycoproteins in addition to Vp54 
[122]. Both of these glycoproteins react with the PBCV‐1 antibody, and so, the glycan 
structures are predicted to be or identical to the glycans associated with Vp54. The gene 
encoding one of these proteins (Vp260) was identified (gene a122r). Gene a122r 
homologs are common in the chloroviruses, and some of the viruses have as many as five 
copies of the gene [123]. The role that Vp260 plays in the PBCV-1 virion is unknown. 
The glycan structures of the MCPs from seven more chloroviruses, which 
represent all four chlorovirus types, were recently reported (Figure 1.9); collectively, all 
of the glycans have a common core region (outlined in Figure 1.8). The common core 
region consists of a pentasaccharide with a β-Glc linked to an Asn residue, which is not 
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located in the typical sequon Asn-X-(Thr/Ser). The Glc has a terminal Xyl unit and a 
hyperbranched Fuc, which is in turn substituted with a terminal Gal and a second Xyl 
residue. The third position of the Fuc unit is always linked to a Rha, which is a semi-
conserved element because its confirmation is virus dependent. Additional decorations 







Figure 1.9. N-glycan structures from seven chloroviruses representing four 
chlorovirus types. Substituents in brackets are not stoichiometric. All sugars are in the 
pyranose form, except where specified. Virus NY-2A is an NC64A virus, virus Osy-NE5 
an Osy virus, viruses ATCV-1 and TN603 SAG viruses and MT325, CVM-1 and NE-JV-




 In addition to the two GTases, hyaluronan synthase and chitin synthase previously 
described, the 43 chloroviruses collectively encode at least eight putative GTases (Table 
1.3). PBCV-1 encodes at least eight putative GTases, some of which, if not all, 
participate in glycosylating the virus Vp54 protein [96, 111, 113]; they are scattered 
throughout the PBCV-1 genome (not shown in Table 1.3; A071R, and HAS and CHS 
proteins). Ongoing experiments have identified the role of three PBCV-1-encoded 
GTases with four GT activities that are involved in the synthesis of the glycan (Figure 
1.10). Two of the three GTases were previously annotated as GTases, but the third 
protein was only identified in a recent study [111]. None of these eight PBCV-1 encoded 
GTases have an identifiable signal peptide that would target them to the ER. 
Furthermore, with the exception of PBCV-1 GTases A473L (six transmembrane 
domains; CESA CelA-like) and A219/222/226R (nine transmembrane domains; CXCX-
2), none of the remaining PBCV-1 encoded GTases are predicted to have transmembrane 
domains. Therefore, these enzymes are expected to be soluble proteins. The genes for the 
PBCV-1 encoded GTases are expressed early during PBCV-1 infection [124]. Thus, 
assuming the enzymes are stable, they would be available for adding sugars to the Vp54 




Figure 1.10. Structure of the glycan attached to the chlorovirus PBCV-1 major 
capsid protein (Vp54) with the predicted PBCV-1 encoded glycosyltransferases. The 
sugar Man and Ara connected by the dashed lines are nonstoichiometric substituents. The 
black box encloses the conserved pentasaccharide core structure common to all 
chloroviruses analyzed to date. The black labeled enzymes have been shown to carry out 
the listed reactions by examining the end products by NMR. The red labeled enzymes 
have been shown to carry out the listed reactions by the GloTM assays. Note that protein 
A064R has 3 domains, each with an independent activity.  
 
Now that structures of the glycans from the chlorovirus MCPs are becoming 
available, one can begin to characterize the viral encoded GTases biochemically. One 
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question that needs to be addressed is: Are the sugars added sequentially to the Vp54 
protein backbone or are the glycans initially synthesized independently of Vp54, possibly 
on a lipid carrier and then attached to the protein in a single step? A slight variation of 
these two possibilities is that the core glycan is synthesized independently of the protein 
and then attached to Vp54. Additional sugars could then be added sequentially to these 
core glycans [96]. We suspect that this viral encoded glycosylation pathway represents a 
previously undescribed pathway, possible even a pathway that existed in eukaryotes prior 
to the ER and Golgi glycosylation pathway [102].  
In the chapters to follow, this thesis will address individual PBCV-1 encoded 
GTases and MTases that participate in the synthesis of the unique glycoforms that 
decorate the virus Vp54 protein independent of the host microalga Chlorella. One by one, 
we will unpack each virus-encoded enzyme with evidence supporting its confirmed or 
predicted role in glycan synthesis (Figure 1.10). Of the eight GTases encoded by the 43 
chloroviruses, only two of them, homologs of PBCV-1 A111/114R and A075L, are 
present in all of the viruses, and so, they are predicted to be involved in the synthesis of 
the core glycan structure. A111/114R is especially interesting because it is predicted to 
have three GT catalytic domains. Similarly, PBCV-1 encodes another three-domain 
protein (A064R) that performs three different functions; however, it is not coded by any 
other chlorovirus for which the glycan structures are already known. The following 
results strongly suggest that GT diversity is in its infancy of discovery. Ultimately, 
further investigation of chlorovirus glycosylation will provide the field of glycobiology 
with new discoveries and may ultimately answer the central question about what benefits 
these viruses have by maintaining their own glycosylation machinery through evolution.  
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1.4. GENETIC MODIFICATION OF CHLOROVIRUSES 
Generating recombinant viruses require a pliable host. Unfortunately, reverse 
genetic manipulation of NC64A genomes is currently not possible and therefore directed 
modification of chloroviruses has yet to be achieved. To overcome this transformation 
bottleneck, we tried to develop a transformation system to generate stable site-directed 
chlorovirus mutants by targeting virus GT-genes to investigate their potential 
involvement in chlorovirus glycosylation. GT-genes were targeted simply because we 
developed an antibody-based selection scheme, described below, that can discriminate 
between wildtype and variant glycans attached to the MCP. Having the ability to carry 
out molecular genetic modifications of chloroviruses, with genomes of 290 to 370 kb, 
would help elucidate the function of both known and unknown, novel virus-encoded 
proteins. However, to date, only a few algal species and essentially none of their viruses 
have been genetically manipulated due to inefficient genome editing methods. Of 
particular note has been the recalcitrance of NC64A to genome modifications. Therefore, 
the development of heterologous gene expression tools for the viral Chlorella-like green 
algal hosts would be an important accomplishment.  
More broadly speaking, genetic modification of chloroviruses would provide 
functional insight into the unusual chlorovirus encoded proteins mentioned previously 
such as hyaluronan synthase, potassium ion channel protein, five polyamine biosynthetic 
enzymes, and as addressed in this thesis, GTases. Furthermore, adoption of a reverse 
genetics system would also allow the exploration of formerly characterized proteins 
having potential scientific and economic benefit. For example, chlorovirus genes encode 
commercially important enzymes such as DNA restriction endonucleases and contain 
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elements for genetically engineering other organisms. Examples include viral promoter 
elements that function well in both monocots and dicots of higher plants, as well as 
bacteria [125, 126], and a translational enhancer element that function in Arabidopsis 
[127]. Chloroviruses have some of the smallest, most primitive forms of highly complex 
proteins that exist in higher organisms serving as a simplified fossil template to study 
biochemical models for mechanistic and structural studies [128]. Therefore, the 
development of a successful and reproducible chlorovirus procedure for achieving 
genetic modification would accelerate the exploration of these microalgae and their 
viruses for a broader range of scientific investigations and biotechnological applications. 
Such an achievement would be a major step forward. 
The studies described here were based on harnessing the RNA-programmable 
CRISPR-Cas9 reverse-genetics pipeline, a bacterial immune system that has been 
repurposed for genome engineering, to induce mutagenicity and recombination in 
chloroviruses. This fast and easy genome editing strategy has accelerated research in 
many fundamental and applied disciplines by allowing the dissection of complex gene 
interactions and the construction of new pathways through synthetic biology. If we were 
successful in using the CRISPR-editing system in chloroviruses, we could knock out a 
variety of virus-encoded genes to observe what effect they would have on virus 
replication.  
1.4.A. Transformation of Green Microalgae 
Microalgae and their viruses are receiving increasing attention for their potential 
usefulness in a number of industrial applications, including bioremediation and the 
production of high-value specialty chemicals [129, 130]. The ability to genetically 
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engineer chloroviruses, in order to study and eventually manipulate their metabolic 
pathways, would greatly enhance the utility of microalgae-chlorovirus counterparts as 
scientifically and industrially important organisms. Considering no current reverse 
genetics system exists in either Chlorella or chloroviruses, we are equally limited in the 
capacity to either characterize gene function or exploit unique virus-encoded proteins. 
With the advent of CRISPR technology and the ongoing discovery of new giant viruses 
and their annotated genomes, we are armed with resources that have yet to be married. A 
significant barrier to genetic transformation in chloroviruses is the inaccessibility of its 
host green alga to genetic manipulation.  
 Since microalgal cells are not able to take up exogenous DNA by nature, several 
genetic techniques have been developed for this purpose. Classical mutagenesis has been 
used for the creation of random mutations and a more directed approach to generate 
specific insertions, deletions or substitutions into the host strain in order to produce the 
desired phenotype [131]. Among transformation methods for the delivery of exogenous 
DNA, the most common techniques are electroporation, Agrobacterium tumefaciens-
mediated transformation, ballistic systems and agitation with glass beads [132-135]. 
Although, most of these techniques have been proven to work with great success in 
model strains such as Chlamydomonas reinhardtii, Phaeodactylum tricornutum, 
Scenedesmus, Ankistrodesmus and some Chlorella sp. [136, 137], there is a lack of 
efficient and stable transformation techniques that can be applied to a broader range of 
microalgae strains.  
Genetic engineering of microalgal strains is difficult due to the great diversity of 
species with a variety of cell sizes, cell wall structures and composition and, likely, 
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unique responses to foreign DNA [138]. Like plant cells, Chlorella cells are surrounded 
by a rigid outer cell wall composed of polysaccharides with a variety of sugars as well as 
lesser amounts of protein and lipid that presumably makes them more difficult to 
transform [139]. DNA delivery can be challenging since DNA has to be transferred 
through the cell wall, plasma membrane and nuclear membrane Moreover, the cells have 
to be able to survive the chemical or mechanical treatment. Therefore, particular methods 
are needed for specific strains and, thus, a broader range of genetic tools have to be 
developed. 
In order to transform Chlorella, various methods including glass beads [140], 
Agrobacterium tumefaciens-mediated transformation [141-143], PEG [144], 
protoplasting [145, 146], and electroporation [147-149] have been developed till now. 
Among these, as a preferred and efficient method, electroporation has also been applied 
to transform various microalgae, such as Chlamydomonas reinhardtii [132], Scenedesmus 
obliquus [150], and Nannochloropsis sp. [151]. Electroporation became a successful 
genetic tool for the transformation of several microalgal species [132, 152], however the 
protocol optimization is often challenging, time-consuming and most importantly, only 
proven in selected Chlorella species (C. ellipsoidea, C. vulgaris, C. minutissima, C. 
zofingiensis and C. pyrenoidosa) [153]. Microalgal species have a different resistance to 
transformation and thus are more or less prone to take up and incorporate exogenous 
molecules into their genomes. Moreover, viability can decrease rapidly when high 
voltages are applied and variations in DNA fragment lengths or macromolecule sizes can 
also decrease the transformation efficiencies [152]. 
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Less traditional methods of microalga-transformation are being explored with 
some success. Karas et al. (2015) [154] and Diner et al. (2016) [155] showed that 
episomal plasmids containing a yeast-derived centromeric sequence CEN6-ARSH4-HIS3 
can be transferred by conjugation from E. coli strains to the diatoms Thalassiosira 
pseudonana and Phaeodactylum tricornutum. Recently, Munoz et al. (2019) [156] 
reported an efficient and stable transformation of the green microalgae Acutodesmus 
obliquus and Neochloris oleoabundans by transferring exogenous DNA from E. coli via 
conjugation. 
1.4.B. CRISPR-CAS9 Genome Editing of Microalgae 
The CRISPR-Cas9 system is a bacterial immune system that has been repurposed 
for genome engineering enabling researchers to manipulate the genome of cells [157-
159]. This fast and easy genome editing system has accelerated research in many applied 
disciplines allowing the dissection of complex gene interactions and the construction of 
new pathways through synthetic biology. Presently, most industrial researchers prefer 
CRISPR technology for algal genome engineering, since it can be used as versatile tool 
for editing a single gene or even a complete metabolic pathway in shorter time than other 
classical genome engineering approaches [160]. Despite algal genome editing being in 
early-stage of development, major progress has been made in demonstrating proof-of-
concept of genome editing using the type-II CRISPR system [161].  
Targeted genome editing using RNA-guided endonucleases is an emerging tool in 
algal biotechnology. After successful establishment of the CRISPR-Cas9 system in 
animal and plant cells, this technology is being evaluated in a variety of algal cells. 
Recently, CRISPR-Cas systems have been widely used to manipulate the genome of both 
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freshwater and marine microalgae [162]. A general overview of different algae and genes 
edited by the CRISPR-Cas9 technology, transformants screening procedures, and Cas9-
induced double-stranded break repair mechanisms is provided in Table 1.4 and discussed 
in detailed as follows. CRISPR technology has been demonstrated in microalgae 
including diatoms to manifest the function of the particular gene(s) and developing 
industrial traits, such as improving lipid content and biomass productivity [163]. 
However, application of Cas9 for algal genome engineering is in preliminary stages. As 
noted above, initial success has been achieved with a few model green algae 
(Chlamydomonas, Nannochloropsis, Phaeodactylum etc. [163-165]). Cas9-driven 
systems have been widely used in most of the studies for targeted knock-in, knock-out 
and knock-down of targeted genes in these algae [164, 166]. Development of methods for 
targeted genome editing of new strains of microalgae through CRISPR–Cas9 technology 




Different CRISPR-Cas-systems-mediated transformation have been reported in 
the model green alga, C. reinhardtii. The first attempt to modify target genes in the 
genome of C. reinhardtii was made in 2014 [167]. Unfortunately, the implementation of 
CRISPR-Cas9 in C. reinhardtii was not as straightforward or as efficient as in other 
model organisms. Previous studies showed highly inefficient gene editing in C. 
reinhardtii using conventional Cas9 and single guide RNA (sgRNA) genes which yielded 
only one colony with a modified target locus per 1.5 × 109 initial cells used for 
transformation [167]. From there, several research teams have developed different 
strategies and methods to transform C. reinhardtii cells either by experimenting with 
CRISPR systems [168], transformation techniques [169], and even by modifying 
CRISPR-associated protein used for the purpose [170]. Altogether, these studies showed 
that different factors and parameters need to be considered for successful CRISPR 
modification in green algae. 
The use of circular recombinant plasmids for CRISPR transformation has been a 
standard method in related research. This plasmid-based approach (Figure 1.11a) 
employees a suitable plasmid backbone into which has been inserted the Cas9 gene 
encoding for its protein and a gene encoding a sgRNA that will hybridize with the target 
gene. After that, the plasmid is digested and linearized with a restriction endonuclease 
enzyme(s) and integrated into the microalgae’s genome following genetic transformation 
(usually via electroporation). Cas9 protein, guided by its sgRNA, then induces a DSB 
(double-strand break) and potential disruption of the targeted gene. An alternative 
approach that avoids many complications inherit in using Cas9 and sgRNA genes is the 
use of ribonucleoprotein (RNP)-mediated CRISPR genome editing or the also called 
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DNA-free CRISPR (Figure 1.11b). This direct delivery of RNPs alleviates difficulties 
with protein expression in cells in which common eukaryotic promoters are not expressed 
well. Indeed, this method does not require the delivery of foreign DNA. In addition, the 











Figure 1.11. Schematic representation on approaches used for CRISPR-Cas9 
system-based algal genome engineering. (a) Integration vector-based approach that 
results in Cas9–sgRNA nuclease complex formation within an algal cell followed by 
double strand DNA cleavage and gap repair by NHEJ or HDR. NHEJ-based gap repair 
most often results in insertion or deletion of nucleotide bases (indels) and this mutation in 
the target gene often results in gene silencing. HDR-mediated DNA repair requires donor 
DNA with homology to the target DNA that allows homologous recombination and 
insertion of new DNA sequences into the target gene (i.e., knock-in mutations). (b) In the 
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RNP-based approach, purified Cas9 protein and laboratory synthesized sgRNA are 
assembled in vitro to form a CRISPR-RNP complex.  These complexes are then 
transformed in competent cells to create gene knock-out mutants.  If DNA fragments 
homologous to the target gene are supplied along with the Cas9/RNP, HDR-directed gene 
modification (i.e., gene knock-in) can occur.  Figure from [162]. 
 
High-efficiency protocols for transformation using CRISPR-Cas9 plasmid-based 
approaches and Cas9/RNPs have been developed for genome engineering of 
photosynthetic microalgae [164, 171]. Recently, a plasmid-based gene-within-a-gene 
(Cas9 gene containing an artificial intron with an inserted sgRNA encoding gene) 
construct was designed and found to be functional in both C. reinhardtii and tobacco 
cells [168]. The authors reported comparatively higher (3 × 10−7) transformation 
efficiency for the FKB12 gene. An arginine auxotroph (arg7-8) was co-transformed with 
Cas9-intron sgRNA and 80 nucleotides ssDNAs complementary to the argininosuccinate 
lyase (ARG) gene, and arginine prototrophs were isolated at much higher efficiency. 
When the authors used a ssDNA oligonucleotide designed to appropriately modify the 
acetolactate synthase (ALS) gene and supplied it along with a Cas9 gene-within-a-gene 
construct targeting the ALS gene, they were able to create a sulfometuron methyl 
herbicide-resistant strain of C. reinhardtii [168]. 
There are a number of reports in which Cas9-RNP-based approaches have been 
used for algal genome engineering. This technology utilizes purified Cas9 protein and in 
vitro synthesized sgRNA. The Cas9 protein and sgRNA are pre-assembled in vitro, and 
directly delivered to algal cells either via electroporation or by biolistic method [166, 
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172]. In C. reinhardtii, Cas9 RNPs comprising Cas9 protein and sgRNAs were directly 
delivered to the cells by electroporation and created targeted mutations in multiple loci 
[166, 173]. RNP-based approaches have also been used to generate more robust strains of 
the industrial alga Coccomyxa as a biofuel cell factory [174]. RNP-based approaches 
have unique advantages and are comparatively simpler than plasmid-based approaches. 
For example, vectors having strong constitutive promoters for Cas9 expression which 
often results in continuous expression and higher production of Cas9 inside the cells. 
Higher concentration of Cas9 may kill the chassis organism by creating a toxic 
environment (e.g. by creating an abundance of non-specific DNA cleavages and/or 
causing a lethal level of off-target mutations).  Cas9-sgRNA complex used in this 
approach requires stringent quality control steps. It is especially important to demonstrate 
in vitro DNA cleavage activity at the desired target site on a PCR amplified target DNA. 
Optimization of sgRNA and Cas9 concentration for assembly of functional RNP and 
development of a robust transformation/RNP delivery system in cells are critical in using 
this approach.  Indeed, transformation of in vitro assembled RNP complex into algal cells 
requires series of optimization to achieve high transformation efficiency. One of the key 
considerations for algae competent cell preparation is growth phase and density of 
cultures which may vary from strain to strain. To our knowledge, overnight grown 
cultures at 0.3–0.5 OD600 are comparatively suitable to achieve higher transformation 
efficiency in Chlamydomonas and Chlorella. Optimization of electroporation methods is 
also specific for different strains. In C. reinhardtii, electroporation is mostly used for 
successful and high-efficiency transformation [167]. 
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CHAPTER II 
CHLOROVIRUS GENETIC TRANSFORMATION 
2.1. OVERVIEW 
The overall goal of this research aim is to develop a transformation system that 
supports the genetic modification of the large dsDNA chloroviruses that infect unicellular 
Chlorella-like green microalgae. Specifically, we aim to leverage CRISPR, an RNA-
guided gene editing technology, to investigate the progression of chlorovirus 
glycosylation that takes place independent of its host cell’s biosynthetic machinery. The 
ability to genetically engineer chloroviruses, in order to study and eventually manipulate 
their metabolic pathways, would greatly enhance the utility of microalgae-chlorovirus 
counterparts as scientifically and industrially important organisms. Considering no 
reliable current reverse genetics system exists in either Chlorella NC64A or 
chloroviruses, we are equally limited in the capacity to either characterize gene function 
or exploit unique virus-encoded proteins. In the advent of CRISPR technology and the 
ongoing discovery of new giant viruses and their annotated genomes, we are armed with 
resources that have yet to be married.  
A significant barrier to genetic transformation in chloroviruses is the 
inaccessibility of its host green alga to DNA or protein uptake. Like plant cells, 
Chlorella cells are surrounded by a rigid outer cell wall composed of polysaccharides 
with a variety of sugars as well as lesser amounts of protein and lipid that presumably 
makes them more difficult to transform. To address these limitations, we developed a 
series of protocols with an original selection scheme designed to introduce exogenous 
DNA and protein in an effort to generate chlorovirus GT-gene mutations. We chose to 
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target another NC64A virus for gene editing, CA-4B. CA-4B-encoded 034r is a homolog 
of PBCV-1 a064r, that encodes for a highly characterized GT with three domains 
involved in protein glycosylation: domain 1 has a β-L-rhamnosyltransferase activity, 
domain 2 has an α-L-rhamnosyltransferase activity, and domain 3 is a MT that decorates 
one position in the terminal α-L-Rha unit [175]. Based on the low methylation levels of 
CA-4B DNA [32], we predict there is less likelihood the CA-4B virion packages 
restriction enzymes unlike PBCV-1 and other chloroviruses. Therefore, upon infection of 
NC64A cells, we believe delivery of any exogenous cargo, like CRISPR editing-RNA 
and Cas protein, is less susceptible to virus-encoded restriction endonucleases.  
The overall strategy to modify chlorovirus DNA involved testing a variety of 
transformation methods that could support the delivery of preassembled Cas9 protein-
sgRNA RNPs to generate a targeted gene cleavage event in the CA-4B putative GT-gene 
034r. Transformation methods that were investigated included protocols with cell wall-
targeting enzymes, electroporation, silicon carbide (SiC) whiskers, and cell-penetrating 
peptides (CPP). The RNA-directed selection of a specific 20–22 bp nucleotide sequence 
within the target gene 034r by the Cas9/sgRNA complex allows the two nuclease 
domains of Cas9 to create a DSB at a predetermined site within the gene of interest. 
Repair of the DSB by the error-prone nonhomologous end joining (NHEJ) DNA repair 
system can result in gene inactivation (i.e., gene knockout). Alternatively, replacement of 
the cleaved DNA segment with a closely related DNA fragment via homologous-directed 
recombination (HDR) can result in gene replacement (i.e., gene knockin) or nucleotide(s) 
substitution. Previously, single-stranded oligodeoxynucleotides (ssODNs) reportedly 
provide 100-fold lower levels of nonhomologous integrations compared with double-
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stranded counterparts [176] and have demonstrated scarless genomic editing capabilities 
with reduced unwanted off-target cutting [170]. Adopting this strategy should increase 
efficiency of targeted DNA editing and replacement in chloroviruses. 
Here, we explored whether targeted DNA cleavage could be used to facilitate 
homology-mediated mutagenesis by using a DNA repair template complimentary to the 
034r gene. We used tandem co-delivery of a DNA template in the form of ssODN with 
Cas9/RNPs to achieve HDR. The ssODN is approximately 80 nt long, designed with 
homology arms extending 40 nt upstream and downstream of the sgRNA target in CA-4B 
034r, respectively (Figure 2.1). The ssODN contained two critical elements that 
permitted selection when incorporated into a mutant virus: (1) a MscI point mutation (T 
to A) that converts the native restriction site TGGCCA to AGGCC, and (2) a nucleotide 
substitution (C to A) that introduces a premature stop codon (TAA). The HDR event 
would remove the MscI restriction site and allow us to verify HDR-mediated insertion by 
treating amplicons with the restriction enzyme to test for DNA replacement at the site of 
Cas9/RNP-mediated DNA cleavage. Amplicons were subsequently sequenced to confirm 
RNP-cleavage. Further, the premature stop codon would eliminate translation of the 
protein resulting in a shortened glycan at the MCP surface of newly formed viruses when 
infected with wild-type PBCV-1. In turn, these virus mutants would be subject to 







Figure 2.1. sgRNA and ssODN designs for targeting CA-4B putative GT-gene 034r. 
Top: Cartoon rendering of CA-4B putative GT-gene 034r composed of three domains. 
Middle: Design of a Cas9/sgRNA gene targeting CA-4B gene 034r to produce mutant 
CA-4B with truncated surface glycans. Shaded gray, sgRNA target site; red TGG, PAM 
site; underlined, MscI restriction site. Bottom: Design of ssODN to replace a dinucleotide 
in the target gene. The homology arms specific to the gene target are flanking the 
nucleotides to be changed (green text). Shaded red, stop codon. 
 
 
2.2. ALGA AND VIRUS, RNP, AND SELECTION 
2.2.A. Materials and Methods 
Alga growth conditions. Chlorella variabilis NC64A cells were grown in Bold’s basal 
medium (BBM) (3 mM NaNO3, 170 M CaCl2 2H2O, 304 M MgSO4 7H2O, 431 M 
K2HPO4, 1.3 mM KH2PO4, 428 M NaCl, 12 M Na2EDTA, 2.2 M FeCl3 6H2O, 1.2 
M MnCl2 4H2O, 220 nM ZnSO4 7H2O, 50 nM CoCl2 6H2O, 99 nM Na2MoO4 2H2O, 
6.4 M CuSO4 5H2O, 184 M H3BO3) modified by the addition of 0.5% sucrose and 
0.1% peptone (MBBM) [94]. All experiments were performed with cells grown to early 
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log phase (4 - 7 × 106 cells/mL). Cell cultures were shaken (200 rpm) at 26 °C under 
continuous light. 
In vitro cleavage assay. Production of chloroviruses PBCV-1, CA-4B and DNA isolation 
were performed as described [177, 178]. Target loci were PCR-amplified and purified by 
2% agarose gel electrophoresis. Purified Streptococcus pyogenes strain Cas9 (SpyCas9) 
and Lachnospiraceae bacterium Cpf1 (LbCpf1) (200 nM) were independently 
preincubated with sgRNA (600 nM) in cleavage buffer [1× NEBuffer 3 (New England 
Biolabs), 10 mM DTT, 10 mM CaCl2] at 37 °C for 15 min. Target DNA (20 nM) was 
added to a final volume of 20 μL. Reactions were incubated at 37 °C for 1 h. Cleavage 
reactions were purified by using a MinElute PCR Purification Kit (Qiagen) and then 
resolved on 2% agarose gels and imaged on a Gel Doc XR+ and ChemiDoc XRS+ 







Figure 2.2. In vitro cleavage assay. The target 034r locus from NC64A virus CA-4B 
was PCR-amplified and incubated with preassembled Cas9 and sgRNA RNP complexes 
in vitro. The complete in vitro cleavage of the target locus confirmed active RNP 
formation. Arrowheads indicate cleaved products. L, ladder. 
 
CA-4B mutant selection using antigenic mutant antibody. NC64A cells were infected 
with CA-4B (MOI 5) and incubated for 12 h. Site-directed mutant viruses were selected 
with anti-Rabbit IgG magnetic beads (RayBiotech) according to the manufacturer’s 
protocol (Figure 2.3a). In summary, rabbit polyclonal antiserum prepared against wild-
type PBCV-1 collected from previous antibody studies [110], which also binds CA-4B, 
was added to the viral lysate and allowed to bind wild-type virus for 1 h. Goat anti-Rabbit 
IgG magnetic beads were incubated with the rabbit antibody solution for 30 min and then 
separated by magnets. The unbound viruses were collected and subsequently incubated 
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for 1 h with rabbit polyclonal antiserum derived from serologically distinct PBCV-1 
mutants that have a mutation in gene a064r, homologous to CA-4B gene 034r, that in 
turn produces truncated surface glycans. Goat anti-Rabbit IgG magnetic beads were 
incubated again with the rabbit antibody solution for 30 min and then separated by 
magnets. After the unbound particulates were washed from the beads, the bound mutant 
antibodies were eluted from the beads using the elution buffer. The beads were then 
magnetically separated from the eluted solution, and the eluted antibodies coupled to 
mutant viruses were removed manually and plaque assayed. Individual plaques were 
selected, and target DNA regions were PCR amplified with specific primers. The PCR 
products were verified by agarose gel electrophoresis, eluted from the gel and sequenced 








Figure 2.3. Recovery of CA-4B site-directed mutants by RNP-targeting. (a) 
Workflow of antibody selection for mutant chloroviruses. Following incubation with 
034r-targeting RNP, macerozyme-treated NC64A cells were infected with CA-4A (MOI 
5). Rabbit polyclonal antiserum (PBCV-1 antibody, green) was added to the viral lysate. 
Goat anti-Rabbit IgG magnetic beads were incubated with the rabbit antibody solution 
and then separated by magnets. The escaped viruses were collected and subsequently 
incubated with antibody derived from serologically distinct PBCV-1 mutants (antigenic 
mutant antibody, red) that have shortened surface glycans. Magnetic beads were 
incubated again with the antibody solution and then separated by magnets. Bound mutant 
viruses were eluted from the beads and plaque assayed. (b) Following antibody selection 
for mutant CA-4B, 13 plaques were recovered. Domain 1 of 034r from each virus isolate 
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was sequenced. (c) Two indels (red) in 034r from two CA-4B variants (1 and 2) were 
detected and sequence verified for site-directed mutagenesis by preassembled Cas9 
protein-sgRNA RNPs in the PBCV-1 a064r homologous gene. PAM site, gray. WT, 
wildtype sequence. 
 
2.3. ENZYMATIC CELL WALL DEGRADATION 
2.3.A. Introduction 
Microalgal cell walls are complex and poorly understood [179]. The Chlorella 
intraspecies variation in cell walls as well as variations observed in a single strain grown 
under different conditions can be dramatic, and thus it is difficult to predict which of the 
compounds noted below will be present in any one strain. While some Chlorella species 
have only a single microfibrillar layer, others have two layers with the microfibrillar layer 
proximal to the cytoplasmic membrane and a mono or trilaminar outer layer [180]. The 
cell walls of C. vulgaris and other green microalgae are known to have rigid wall 
components embedded within a more plastic polymeric matrix [181]. This matrix is 
defined as the fraction that is hydrolyzable in 1 N NaOH or 2 M triflouroacetic acid 
(TFA) and contains uronic acids, Rha, Ara, Fuc, Xyl, Man, Gal, and Glc. The rigid, TFA-
resistant cell wall is either glucosamine or a Glc-Man polymer [182]. The predominant 
amino sugar found in the rigid cell wall of Micractinium conductrix Pbi is N-
acetylglucosamine present as a chitin-like glycan. Chitin (poly-β-1,4-D-N-
acetylglucosamine), a polymer commonly found in shellfish, insects, fungi, worms, and 
mushrooms which can be deacetylated, either partially or fully, to produce chitosan 
(poly-β-1,4-D-glucosamine). Strong acid (6 N HCl) can hydrolyze the rigid cell wall of a 
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Chlorella sp., which removes the acetyl group from N-acetylglucosamine leaving 
glucosamine while hydrolysis with strong sulfuric acid fails to release detectable neutral 
sugars. This suggests that this strain of Chlorella does not have cellulose in the rigid cell 
wall.  
Digestion of the rigid wall with chitinase releases N-acetylglucosamine yet 
complete digestion requires a chitosanase, which indicates that glucosamine polymers are 
also present in the rigid wall of Micractinium conductrix Pbi [183]. Based on these 
previous studies, the genus Chlorella was in-part defined as containing glucosamine as 
the common dominant cell wall polymer [184]. The neutral cell wall sugars of symbiotic 
Chlorella strains contain in decreasing amounts the sugars Glc, Rha, Ara, Man, Xyl, Fuc, 
and Gal, respectively [185]. Other than the neutral sugars (25 %), the cell wall contained 
15–20 % uronic acids, 10–15 % glucosamine, and 6–10 % protein. This cell wall 
composition was reported to be similar to the glucosamine containing cell wall 
composition of the non-symbiotic algae C. vulgaris, C. sorokiniana, and C. kessleri; 
however, the authors were unable to determine the composition of 30–44 % of the cell 
wall [185]. Previously [186], isolated Chlorella NC64A cell walls were analyzed for 








Table 2.1.  
Monosaccharide composition of Chlorella variabilis NC64A cell wall from Meints et al. 
Virol. J. (1988).  
         
Sugar      Mole percent          Percent of  
     Soluble fraction  
Arabinose  5.3   2.6 
Fucose   0.7   0.3 
Galactose  9.1   4.5 
Glucose  51.3   25.5 
Mannose  5.3   2.6 
Rhamnose  16.0   8.0 
Xylose   5.5   2.7 
Glucosamine  6.9   3.4  
 
Total   100.0   49.6   
 
 
Enzymatic digestion of algal cell walls has been previously studied as a 
methodology to make protoplasts of algal cells usually in cell preparation for genetic 
transformation. Protoplasts of C. saccharophila and C. ellipsoidea were made using an 
enzyme mix containing cellulase, hemicellulase, and pectinase activities [187]. However, 
these green algae, which are presumed not to have an outer layer or sporopollenin (now 
known as algaenan), required up to 90 h to display any effect from the enzymes. The cells 
became very sensitive to physical pressures, bursting simply from the pressure of a cover 
slip placed on a microscope slide. Similarly, protoplasts were made from C. vulgaris K-
73122 using acromopeptidase, cellulase, chitosanase, gluczyme, and uskizyme; however, 
only 88 % of the cells were considered osmotically labile [188]. Protoplasts were also 
made in C. ellipsoidea, C. vulgaris, and C. saccharophila using three different enzyme 
mixes containing cellulase, macerozyme, pectinase, cellulysin, and driselase, although 7 
 67 
of the 12 strains tested showed no protoplast formation with any of the formulations 
[180].  
In the work presented here, we sought to define the extent of degradation that a 
variety of enzymatic activities have on the cell walls of NC64A. As the cell wall provides 
the main protective barrier between the algae and its surroundings, a detailed 
characterization of enzymes that act on the wall could enable the rational design of an 
enzyme cocktail that would allow efficient degradation of the wall and delivery of 
CRISPR-targeting cargo. Removal of the wall could allow more efficient transformation 
technologies to be developed. Finally, our findings could provide broader insight on the 
conversion of these cell wall sugars into a more usable substrate for downstream 
processes, or potentially ease lipid extraction from these organisms.  
2.3.B. Materials and Methods 
Cell wall-degrading enzymes. Achromopeptidase, alginate lyase, -amylase (960 FAU/ 
mL), chitinase, chitosanase (25.9 U/mL), chondroitinase ABC (5 U/mL), drieselase, -
galactosidase (1,000 U/mL), -glucosidase, hemicellulase, heparinase II (10 U/mL), 
hesperidinase, hyaluronidase, kitalase, laminarinase, lyticase, lysing enzymes from 
Aspergillus sp., lysozyme, mutanolysin (10 U/mL), pectinase (3,000 U/mL), pectolyase, 
phospholipase A1 (10 kU/mL), phospholipase A2, proteinase K, sulphatase (3.37 mg/mL), 
and trypsin were purchased from Sigma. -glucuronidase (140 U/mL) was purchased 
from Roche. Neuraminidase (50 kU/mL), -N-acetylhexosaminidase (5 kU/mL), -N-
acetylglucosaminidase (4 kU/mL), -1-6 mannosidase (32 kU/mL), -2-3 neuraminidase 
(50 kU/mL), 1-2,3 mannosidase (40 kU/mL), and endo--N-acetylgalactosaminidase 
(40,000 kU/ mL) were purchased from New England Biolabs (Ipswich, MA). Glusulase 
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was purchased from NEN Life Science Products ( Boston, MA) (10,000U sulfatase and 
90,000 U -glucuronidase/mL). Zymolyase (10 mg/mL) was purchased from 
ZymoResearch (Irvine, CA). Macerozyme was purchased from RPI corp (Mt Prospect, 
IL). Cellulase was purchased from Sigma Aldrich (St. Louis, MO). Stock concentrations 
of enzymes were 20 mg/mL unless otherwise noted. 
Enzyme inhibition assay. To assay growth inhibition due to enzymatic activity, 200 L 
of algal cells normalized to an OD750 of 1.0 was mixed with 4 mL of media containing 
7.5 g/L agar, which was at 42 °C and poured on a petri plate containing 15 g/L agar. 
Once hardened, 10 L of enzyme stock was then spotted on the top agar and plates were 
incubated in the light at 26 °C for 5 days. As a negative control for enzymatic activity, 
enzymes were heat denatured at 100 °C for 10 min and spotted on plates. 
Flow cytometry. Cell permeability assays were performed on the BD FACSAria cell 
sorter using ATTOTM 550 labeled Alt-RTM Cas9 tracrRNA (IDT 1075928). One L of 
ATTOTM 550 labeled tracrRNA (200 uM) was added, incubated for 2 min, and loaded on 
the BD FACSAria where 20,000 cells were imaged. Samples were excited using a 488 
nm laser and 660–740 nm (chlorophyll) and 480–560 nm (ATTO) emission data as well 
as bright field image data were collected. Populations were gated for in-focus cells and 
analyzed for permeability. 
NC64A transfection by enzymatic digestion. One mL of cell culture of NC64A (5 × 
106 cells) was taken, centrifuged at 8,000 rpm for 5 min, and the pellet was resuspended 
in the same volume of a MBBM in the presence of cell wall-degrading enzymes (Table 
2.2) or MBBM only. The culture was incubated for 24 h at 25 °C in continuous light. 
NC64A cells were centrifuged and resuspended in a solution (0.8 M NaCl and 0.05 M 
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CaCl2). Prior to NC64A cells being tested for transforming activity with RNPs, all treated 
cells were previously infected with virus and analyzed by plaque assay to confirm treated 
cells retained their permissive qualities required for virus attachment and infection. To 
generate target-specific site-directed mutants using RNP complex in NC64A, enzyme-
treated and nontreated cells were transformed with either Cas9 protein or Cpf1 (200 μg) 
premixed with 034r-targeting sgRNA (140 μg). Cas9 and Cpf1 proteins in storage buffer 
(20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, and 10% glycerol) were mixed 
independently with sgRNA dissolved in nuclease-free water and incubated for 10 min at 
room temperature. The cell mixtures were incubated for 15 min at room temperature. 
Enzyme-treated NC64A cells were then infected with CA-4B and incubated overnight. 
Virus mutants were selected using the same antibody selection assay previously 
described. Virus plaques were analyzed by PCR and sequenced to detect Indel mutations 












Table 2.2.  
Growth inhibition of Chlorella variabilis NC64A by a variety of enzymes  
       
 
Enzyme   NC64A 
       
 
Cellulase   − 
Chitinase   + + + 
Chitosanase   + 
Driselase   − 
β-Glucosidase   − 
β-Glucuronidase  − 
Hyaluronidase   − 
Laminarinase   + + + 
Lysozyme   + + + 
Lyticase   + + + 
Macerozyme   + + + 
Pectinase   + + + 
Pectolyase   − 
Sulphatase   + 
Trypsin   − 
Zymolyase   − 
       
−, no growth inhibition; +++, complete growth inhibition 
 
 
2.3.C. Results and Discussion 
To access enzyme activity against algal cell walls, we developed a reasonable 
throughput growth inhibition assay on agar plates, where the ability to inhibit growth was 
compared to heat denatured enzyme. Growth inhibition suggests the enzyme is either 
degrading the cell wall during construction or the enzyme interferes with precursor 
generation prior to assembly into the cell wall. From a variety of enzymes tested, 
chitinase, laminarinase, lysozyme, lyticase, macerozyme, and pectinase had the broadest 
effect on Chlorella NC64A (Table 2.2) based on the zone of inhibition around the spotted 
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area while chitosanase and sulphatase demonstrated minor growth inhibition by 
comparison. Heat denatured enzymes did not impact growth in our assay, indicating the 
growth inhibition was due to the enzymatic activity alone and not from other potentially 
toxic components of the enzyme preparations (data not shown). In one study [181], 14 
different strains of Chlorella were challenged with cell wall-degrading enzymes and no 
two strains had the same pattern of inhibition. This large range of sensitivity to various 
enzymatic activities illustrates the wide diversity of cell wall composition amongst the 
alga Chlorella species. Our results show that in methodologies or processes using intact 
algal cells or residual algal biomass, enzymatic treatment can have large impacts on the 
permeability of the algal cell walls and may be useful in optimization.  
After finding enzymes that inhibited growth, we examined their effects on cell 
walls of actively growing cultures. To process a large number of enzymes individually 
and in combination, we developed a rapid assay that would give statistically relevant 
results. We postulated that degradation of the cell wall may have dramatic effects of the 
cell membrane as well, which could lead to an altered permeability barrier. Cell 
permeability due to enzymatic disruption of the wall was visualized using an imaging 
flow cytometer, the BD FACSAria. To evaluate translocation of the RNP across the cell 
wall/membrane barrier, we used the 67mer Alt-RTM CRISPR-Cas9 tracrRNA (IDT) that 
has a ATTOTM 550 fluorescent dye attached to the 5’ end. The fluorescent dye allows for 
a visual analysis of transfected cells and cell sorting by FACS. During data acquisition, 
algal cells were positively defined by their chlorophyll autofluorescence. A minimum 
chlorophyll autofluorescence was set to eliminate potential false positives from bacteria 
and debris present in the culture. The resultant data were analyzed by setting a minimum 
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ATTOTM 550 fluorescent intensity threshold, such that the majority of untreated cells 
(Figure 2.4a) had fluorescence intensity lower than the threshold. Cells with a fluorescent 
intensity above this threshold were considered permeable to the tracrRNA dye as 
indicated by cells pretreated with macerozyme (Figure 2.4b), or vortexed with SiC 







Figure 2.4. FACS dot plot analysis of fluorescently labeled NC64A cells. NC64A cells 
were visualized by intracellular incorporation of fluorescently labeled tracrRNA 
(ATTOTM 550), (a) without enzyme treatment, or prior to FACS were (b) macerozyme 
digested, (c) vortexed with SiC whiskers, or (d) electroporated. Cells were illuminated 




collected in the bright field and 480–560 nm emission (ATTOTM 550 fluorescence) 
channels. Cell populations with a high fluorescent intensity were gated for in-focus cells 
and analyzed for permeability.  
 
We have shown previously that CA-4B reacts with PBCV-1 antibody making it 
useful to precipitate wild-type CA-4B virus [32]. In addition, studies involving 
spontaneous mutant viruses have demonstrated previously that disruption of PBCV-1 
a064r leads to viruses with an altered glycan attached to the MCP and that they are 
antigenically different from wild type PBCV-1 [107]. Polyclonal antisera were prepared 
against these spontaneous mutants. This allowed us to screen for the suspected a064r 
disrupted gene with antibody that specifically recognized viruses with this mutation. 
Following incubation with the serologically distinct antigenic antibody, the putative 
mutant precipitate was eluted, and plaque assayed (Figure 2.3a). The resulting plaques 
were subsequently verified by DNA sequencing of domain 1 from 034r using appropriate 
PCR primers. Two isolated plaques showed separate indels at the target site supporting 
evidence of site-directed mutagenesis by RNP-targeting in the PBCV-1 a064r 
homologous gene, CA-4B 034r (Figure 2.3b and 2.3c). These results demonstrate 
successful delivery of preassembled Cas9 protein-sgRNA RNPs that resulted in 
frameshift mutations in the CA-4B-encoded gene 034r. However, despite exhausting a 
number of trails and alternative enzyme combinations, we were unable to duplicate these 
results. It is unlikely detection of the mutant virus DNA was due to erroneous sequencing 
given all samples were sequenced in triplicates with consistent readings. 
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All attempts at producing HDR using ssODNs to remove the native MscI 
restriction site in 034r were unsuccessful. Amplicons of the putative GT-gene from 
recovered CA-4B plaques after antibody selection were incubated with MscI. Digestion 
of virus DNA produced DNA fragments consistent with an intact MscI site (restriction 
digestions not shown). The conservation of the restriction site demonstrates no evidence 
of ssODN-mediated HDR. 
 One possible explanation for obtaining the RNP-mediated NHEJ event in CA-4A 
DNA is macerozyme successfully eroded the alga cell wall, promoting cell permeability, 
allowing the entrance of the RNP-targeting cargo (Figure 2.4b). Despite targeting cell-
wall polymers, the crude multi-component enzyme mixture containing pectinase, 
hemicellulase, and cellulase (amounts decreasing in order) did not compromise the host 
receptor enough to prevent virus attachment as evident by a productive virus infection. 
The host receptor, which is likely a carbohydrate [81], is uniformly present over the 
entire surface of the alga. Once inside the cell, deposited viral DNA could be recognized 
by the GT gene-targeting RNPs. However, this doesn’t explain why SiC and 
electroporation procedures were unsuccessful in obtaining mutant viruses given evidence 
of RNP delivery inside NC64A was greater using these delivery techniques compared to 
macerozyme-treated cells (Figure 2.4c and Figure 2.4d). Perhaps the fluorescently 
labeled cells, although in greater quantity, were either dead or compromised in health that 
prevented the desired viral DNA editing. 
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2.4. SILICON CARBIDE WHISKERS 
2.4.A. Introduction 
 We were interested in developing a simple, inexpensive technique for introducing 
DNA into walled algal cells. In 1990, Kaeppler [189] reported using SiC whiskers to 
mediate the introduction of DNA into plant cells. We adopted a technique based on the 
SiC method of Kaeppler that uses SiC whiskers to transform the microalgae C. 
reinhardtii with its intact cell wall [190]. This SiC method reported transformants at an 
efficiency of up to 10−5 per cell for walled cells and up to 10−4 per cell for cw-15 strains 
(protoplast). In contrast to agitation of the cells with glass beads, agitating the cells with 
SiC whiskers for up to 10 min resulted in little loss in cell viability. The gentle nature of 
the SiC protocol may allow more flexibility in the development of protocols for the 
transformation of Chlorella strains.  
The SiC whiskers method involves the mixing (e.g., by vortex treatment) of cells 
in liquid medium with whiskers and exogenous DNA and/or protein. The resulting 
collisions between cells and whiskers appear to lead to cell penetration and DNA delivery 
[191]. Here, we aimed to utilize FACS again to evaluate the delivery of fluorescently 
labeled CRISPR-targeting cargo inside NC64A using the SiC whiskers method. 
2.4.B. Materials and Methods 
NC64A transfection by SiC whiskers. For each transformation, cells were mixed with 
sterile SiC whiskers and preassembled Cas9 protein-sgRNA RNP +/- ssODNs armed 
with the protospacer sequence targeting domain 1 of CA-4B 034r. Samples were agitated 
by a vortex mixer at top speed for 2 min, stopping briefly every 10 s. Immediately after 
vortexing, samples were diluted with PEG and infected with CA-4B. Following overnight 
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infection, virus mutants were selected using the same antibody selection assay previously 
described. Virus plaques were analyzed by PCR and sequenced to detect Indel mutations 
by NHEJ, while 034r amplicons were also incubated with MscI to screen for ssODN-
mediated HDR. 
2.4.C. Results and Discussion 
FACS analysis of the SiC whiskers treated NC64A cells showed between 10-20% 
cell fluorescence (Figure 2.4c) suggesting positive delivery of the RNPs inside the alga 
cells. We speculate that cell wall perforations allowed RNP complexes brief access inside 
the cell. Immediately following electroporation, cells were infected with CA-4B. In 
theory, once viral DNA was deposited inside the alga cell, the naked nucleic acid would 
be available for RNP-binding and subsequent 034r cleavage. The edited viral DNA 
would be subsequently replicated and packaged. Following antibody selection, we 
expected to recover an NHEJ indel event in CA-4B at the RNP-designated target site, 
however, we were unsuccessful. Although virus plaques were recovered, sequencing 
results confirmed the wildtype 034r was intact. Given these sequencing results, these 
plaques were likely caused by escape viruses that evaded wildtype antibody binding. 
2.5. ELECTROPORATION 
2.5.A. Introduction 
Electroporation is widely used for transformation of competent and non-
competent bacteria, yeast, mammalian and microalgae cells [192]. This technique 
involves the use of high-intensity electric pulses to induce the permeabilization of the cell 
membrane, thus allowing the uptake of DNA directly from the surrounding environment. 
The effectiveness of transformation through this method is mediated by length of the 
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electric pulses, the composition of the medium, presence or absence of a cell wall, 
concentration of the heterogeneous DNA and strength of the electric field. The medium 
often demonstrates an increase in temperature after the procedure and as a result, a 
portion of the cells present in the suspension will be lost. Electroporation has already 
been successfully used for the transformation of many microalgae species such as C. 
reinhardtii, Nannochloropsis sp., Dunaliella sp., and some Chlorella sp. not including 
NC64A [145].  
Transformation of Chlorella cells via the method of electroporation alone must be 
performed under extreme conditions (high voltage and long pulse) that can cause damage 
to cells, affecting their ability to function normally. Even under such extreme conditions, 
mostly transient transgene expression has been achieved [193]. Widely used in bacteria, it 
can be used for microalgae that have a weakened cell wall [194]. In the microalgae, C. 
ellipsoidea and C. reinhardtii, mutant strains without cell walls are easy to transform 
[135, 146], suggesting that other Chlorella species such as NC64A can have the same 
transformation potential if the physical barrier of the cell wall is eliminated. The 
thickness of the cell wall of the free-living C. variabilis is between 11–17 nm and that of 
the symbiotic C. variabilis is 6–10 nm [195]. A major wall component is chitin, a 
glucosamine polymer not normally present in green algae likely contributes to the cell’s 
impermeability. The total makeup of the NC64A cell wall isn’t completely known, 
however Glc is the main structural component [186], and therefore, its dilution or 
elimination by use of digestive enzymes prior to electroporation could be a crucial step 
for reliable transformation. 
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2.5.B. Materials and Methods 
NC64A transfection by electroporation. Purified Cas9 (100 μg) was preincubated at a 
1:3 molar ratio with three 034r-targeting sgRNAs at 37 °C for 15 min to form RNP 
complexes. For transfection, 250 μL cell culture (2.5 × 108 cells/mL) supplemented with 
sucrose (40 mM) were mixed with preincubated RNPs, and ssODNs. Cells were 
electroporated in 2-mm cuvettes (600 V, 50 μF, 200 Ω) by using Gene Pulser Xcell 
(Biorad). Immediately after electroporation, 800 μL of MBBM with 40 mM sucrose was 
added to the sample and the cells were infected with CA-4B (MOI 5). Following 
overnight infection, virus mutants were selected using the same antibody selection assay 
previously described. Virus plaques were analyzed by PCR and sequenced to detect Indel 
mutations by NHEJ, while 034r amplicons were also incubated with MscI to screen for 
ssODN-mediated HDR. 
2.5.C. Results and Discussion 
FACS analysis of the electroporated NC64A cells showed the highest cell 
fluorescence of all delivery methods (approximately 20%) suggesting positive delivery of 
the RNPs inside the alga cells (Figure 2.4d). We speculate that electroporation-induced 
cell wall perforations allowed RNP complexes brief access inside the cell. Immediately 
following electroporation, cells were infected with CA-4B. In theory, once viral DNA 
was deposited inside the alga cell, the naked nucleic acid would be available for RNP-
binding and subsequent 034r cleavage. The edited viral DNA would be subsequently 
replicated and packaged. Following antibody selection, we expected to recover an NHEJ 
indel event in CA-4B at the RNP-designated target site, however, we were unsuccessful. 
Although virus plaques were recovered, sequencing results confirmed the wildtype 034r 
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was intact. Given these sequencing results, these plaques were likely caused by escape 
viruses that evaded wildtype antibody binding. 
2.6. CELL-PENETRATING PEPTIDES 
2.6.A. Introduction 
CPPs are short peptides that facilitate cellular intake and uptake of molecules. 
This group of short peptides with at most 30 to 35 amino acid residues, has the ability to 
translocate across the cell membrane [196]. In animal system, the direct protein delivery 
strategy using CPPs has been extensively developed [197-199]. However, the peptide-
mediated protein delivery system in plants and algae are still scarcely developed. CPPs 
are of different sizes, amino acid sequences, and charges but all CPPs have one distinct 
characteristic, which is the ability to translocate the plasma membrane and facilitate the 
delivery of various molecular cargoes to the cytoplasm or an organelle; thus, they act as 
molecular delivery vehicles. There has been no real consensus as to the mechanism of 
CPP translocation, but the theories of CPP translocation can be classified into three main 
entry mechanisms: direct penetration in the membrane, endocytosis-mediated entry, and 
translocation through the formation of a transitory structure.  
Previous studies demonstrated that CPP-fused to a polycationic peptide (an 
alternate copolymer of lysine and histidine, (KH)9), which was termed as fusion peptides, 
is a more efficient nucleic acid carrier compared with that of the CPP alone in intact 
plants [200]. By using the fusion peptides, the negatively charged cargo preferentially 
interacts with the polycationic peptide through ionic interactions, whereas the CPP 
interacts with fewer cargo molecules and is preferentially present on the surface of 
peptide-cargo complexes. The higher number of CPPs at the surface of the complexes 
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leads to a higher efficiency in gene delivery [201]. Based on the concept of fusion 
peptide, two protein delivery carriers, (BP100)2K8 and BP100(KH)9, were designed by 
fusing a CPP, i.e., BP100 or BP100 dimer, and a polycationic peptide, i.e., alternate 
copolymer of lysine and histidine, (KH)9 or eight consecutive lysine residues, K8. The 
polylysine is known to destabilize cell-membrane via electrostatic interaction between the 
protonated amine and the negatively charged cell membrane [202]. On the other hand, the 
copolymer of lysine and histidine has the ability to promote the buffering effect on the 
prelysomal vesicle [203]. In this current study, we assumed that the polycationic peptides 
[(KH)9 and K8] also play an important role in the electrostatic interaction with negatively 
charged protein cargo, similarly to the ionic interaction with plasmid DNA as described 
in previous studies [200, 204].  
2.6.B. Materials and Methods 
Peptides. Peptides were gifted by Dr. Heriberto Cerutti (UNL): (BP100)2K8 
(KKLFKKILKYLKKLFKKILKYLKKKKKKKK, theoretical pI/Mw: 10.75/3851.13 Da) 
and BP100(KH)9 (KKLFKKILKYLKHKHKHKHKHKHKHKHKH, theoretical pI/Mw: 
10.81/ 3809.71 Da). 
Complex formation. Peptide/RNP complexes were prepared by adding different 
amounts of each peptide to RNP at various ratios (0.1, 0.5, 1, 2, 5, 10, and 20). The 
solution was thoroughly mixed by repeated pipetting and allowed to stabilize for 30 min 
at 25 °C.  
NC64A transfection by CPPs. Referring to a previous study [173], 10 μg of Cas9 and 
12 μg of sgRNA were incubated at room temperature for 15 min. A prepared cell sample 
of 100 μl at 3 × 108 cells/mL was added to the incubated RNP, ssODNs, and gently 
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mixed. Tested independently, (BP100)2K8 or BP100(KH)9 was added to the sample and 
mixed immediately. In a series of experiments, we observed that there was no significant 
difference between the two types of treatment with CPPs: (1) pre-incubation of RNP and 
CPP for the formation of complex, and (2) treatment of CPP and RNP to the cell 
simultaneously. After incubation of the cells mixed with the RNP and CPP for 30 min at 
25 °C, trypsin was added, and the mixture was incubated for 15 min at 37 °C. The sample 
was washed by MBBM media and transferred to 10 mL of MBBM media and incubated 
for 16 h under dim light without shaking as a “recovery” step. Following incubation, cells 
were infected with CA-4B (MOI 5) and incubated overnight (24 h). Following overnight 
infection, virus mutants were selected using the same antibody selection assay previously 
described. Virus plaques were analyzed by PCR and sequenced to detect Indel mutations 
by NHEJ, while 034r amplicons were also incubated with MscI to screen for ssODN-
mediated HDR. 
2.6.C. Results and Discussion 
We examined the effect of parameters, such as the peptide/RNP ratio and serum 
addition, on peptide-mediated transfection. Properties of peptides (DNA binding stability 
and condensation capacity) and of peptide/RNP complexes (size and surface charge) 
were investigated because these are known to vary as a function of the peptide/RNP ratio. 
Following antibody selection, we expected to recover an NHEJ indel event in CA-4B at 
the RNP-designated target site. However, we were unsuccessful. Although virus plaques 
were recovered, sequencing results confirmed the wildtype 034r was intact. Given these 
sequencing results, these plaques were likely caused by escape viruses that evaded 




Agrobacterium tumefaciens is a gram-negative bacterium species found in soil, 
more commonly known for infecting a wide variety of dicotyledonous plants, causing the 
growth of tumors on their stems near the surface of the soil (a disease referred to as 
crown gall disease). The infection is triggered by the release of phenolic compounds from 
wounds in plant roots and is controlled by the “vir regulon” present in the Ti plasmid. 
This leads to the transfer of the T-DNA from the bacterium’s Ti plasmid (tumor inducing 
plasmid) into the plant cells where it permanently integrates into the host genome causing 
the aforementioned tumors [133]. It was later discovered that disarmed Ti plasmids could 
be used to deliver foreign DNA into plant cells in order to produce genetically engineered 
plants with improved features [205].  
More recently it was demonstrated that this same system could also be used to 
transform microalgae [133]. This technique holds several advantages over other 
transformation methods. Not only does it allow the transfer of large DNA molecules with 
little rearrangements, but also demonstrates a high rate of integration into potentially 
transcribed regions and usually leads to the integration of a singular transgene in the 
target’s genome [141]. In contrast with other transformation procedures, transformation 
frequency and gene stability do not appear to be frequent complications and can also 
result in homologous recombination facilitating the localization of the integrated DNA 
segments. Agrobacterium tumefaciens-mediated transformation is a form of conjugation 
as it also involves the physical contact between the organisms involved in the process.  
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Kumar et al. (2004) [147] were able to implement this method for the first time in 
an algal system through the nuclear transformation of C. reinhardtii. When compared 
with other approaches like the glass bead method, transformation mediated by 
Agrobacterium was shown to have an increase in transformation frequency of 50-fold 
when transforming C. reinhardtii. In addition, it allows for the nuclear transformation of 
microalgae without the need for the removal of the cell wall, a trait only shared with 
particle bombardment. 
These aforementioned alga transformation protocols except particle bombardment 
often utilize cell wall less strains or require an enzymatic step to facilitate the removal of 
the cell wall prior to transformation. In light of these stepwise procedures, we were 
interested in the development of a transformation system that doesn’t require alga cell 
wall treatment. Here, we transferred T-DNA of A. tumefaciens strain LBA4404 harboring 
the binary vector pCAMBIA1304 containing the gfp:gusA fusion reporter, a hygromycin 
phosphotransferase (hpt) selectable marker driven by the CaMV35S promoter, and the 
transgene a064r-D1 from PBCV-1 antigenic mutant EPA-1. NC64A Transformation was 
assessed by monitoring transient β-glucuronidase (GUS) and gfp expression 2 days p.i. In 
theory, if NC64A transformation is achieved, the hygromycin-resistant recombinant alga 
expressing the truncated form of A064R (domain 1 only per nonsense mutation) would 
produce some shortened EPA-1 glycans at the MCP surface of newly formed viruses 
when infected with wild-type PBCV-1. In turn, these virus mutants would be subject to 
antibody selection as described above.  
2.7.B. Materials and Methods 
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Agrobacterium strain and vectors. The binary vector pCAMBIA1303 containing a 
gfp:gusA fusion reporter,  domain 1 of gene a064r from a PBCV-1 antigenic mutant 
referred to as EPA-1, and a selectable marker for hygromycin B resistance driven by the 
CaMV 35S promoter were used for transformation. The binary vector was mobilized into 
A. tumefaciens strain LBA4404 by using the Gene Pulser Xcell electroporator (Biorad) 
according to manufacturer’s protocol. Transformed cells were aliquoted and maintained 
at -80°C in 25% (v/v) glycerol. 
Antibiotic sensitivity test. The sensitivity of A. tumefaciens towards the antibiotic 
cefotaxime was tested by inoculating 200 L of Agrobacterium culture (OD600 = 1.0) in 5 
mL LB broth supplemented with varying concentrations of cefotaxime (0, 50, 100, 150, 
200, 300, 400 and 500 mg/L) and the growth of Agrobacterium in each concentration was 
measured spectrophotometrically at OD600 after 2 days. The effect of the antibiotic 
cefotaxime on the viability of NC64A was accessed by plating a serially-diluted 
microalgae culture on solid MBBM supplemented with different concentrations of 
cefotaxime (0, 100, 200, 300, 400 and 500 mg/L). The agar plates were incubated in the 
dark for 2 days at 25 °C before exposure to light and the number of surviving colonies 
from the dilution that produced less than 100 colonies was counted in duplicates after 2 
weeks. In order to determine the minimum inhibitory concentration of hygromycin B, 1 x 
106 NC64A cells were plated on solid MBBM medium supplemented with 500 mg/L 
cefotaxime and varying concentrations of hygromycin B (6, 8, 10, 12, 14, 16, 18, 20, 23 
and 26 mg/L) and each treatment was tested in triplicates. The agar plates were incubated 
for 2 days in the dark at 25 °C before exposure to light and the number of surviving 
colonies was accessed after 20 days.  
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NC64A transfection by Agrobacterium. A general transformation procedure for NC64A 
was established based on work done by Kumar et al. (2004) [133] on transformation of 
C. reinhardtii with some adjustment as described here. Single colonies of Agrobacterium 
initiated from a frozen stock were used to inoculate 10 mL of LB supplemented with 5 
mM Glc, 100 mg/L streptomycin and 50 mg/L kanamycin and grown overnight in a 
rotary shaker at 27 °C with shaking at 200 rpm in the dark. Five mL of this overnight 
culture was used to inoculate 50 mL of the same medium and it was grown in the dark at 
27 °C with shaking at 200 rpm until OD600 = 0.8–1.2. The bacterial culture was harvested 
by centrifugation and washed once with induction medium (MBBM plus 150 M 
acetosyringone, pH 5.6) and diluted to a final density of OD600 = 0.5. Prior to co-
cultivation, a total of 5 x 106 NC64A cells from a log-phase culture (OD600 = 0.5–1.0) 
were pre-cultured for 5 days on MBBM agarose plates at 25 °C and harvested with 
induction medium on the day of co-cultivation. The algal cell pellet was mixed with 200 
L of the bacterial suspension and plated on induction medium solidified with 1.2% 
(w/v) bacto-agar. Co-cultivation was performed for 3 days at 25 °C in the dark. 
Following co-cultivation, cells were harvested with MBBM supplemented with 500 mg/L 
cefotaxime in a total volume of 7 mL and incubated in the dark at 25 °C for 2 days to 
eliminate Agrobacterium. Visualization of gfp expression was performed using a 
confocal fluorescent microscope (Nikon A1R-Ti2 confocal system, UNL Microscopy 
Core). Subsequently, the remaining cells were plated on selective media containing 20 
mg/L hygromycin B and 500 mg/L cefotaxime and incubated at 25 °C in the dark for 2 
days before exposure to light. Resistant colonies were propagated on non-selective media 
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and utilized for PCR analysis. Detection of contaminating Agrobacterium was performed 
by growing cells on LB agar plates for at least 7 days at 25 °C in the dark.  
2.7.C. Results and Discussion 
A. tumefaciens was suppressed at a cefotaxime concentration as low as 50 mg/L 
(Figure 2.5a) whereas the growth of NC64A was found to be uninhibited in cefotaxime-
supplemented media up to 500 mg/L (Figure 2.5b). Thus, the highest concentration (500 
mg/L) of cefotaxime was selected for all experiments to ensure thorough elimination of 
Agrobacterium post-transformation. The lowest concentration of hygromycin B which 
completely inhibited the growth of NC64A was 20 mg/L (Figure 2.5c), and this 




Figure 2.5. The effects of antibiotics on Agrobacterium and NC64A. (a) The effect of 
cefotaxime on Agrobacterium viability. The effect of (b) cefotaxime and (c) hygromycin 














































































































Colony PCR of Agrobacterium colonies post electroporation with the 
recombinant pCAMBIA1303 validated the binary vector was successfully mobilized 
LBA4404 (Figure 2.6a). A total of eight putative hygromycin-resistant single colonies 
that appeared within 20 days on selection media (containing 20 mg/L hygromycin and 
500 mg/L cefotaxime) were randomly selected and grown in liquid media (containing 
500 mg/L cefotaxime but lacking hygromycin) before the DNA was extracted and used in 
PCR analysis. Amplification with EPA-1 a064r domain 1 gene-specific primers 
successfully detected the 633 bp a064r gene fragment (25 kDa) from seven putative 
transgenic lines (Figure 2.6a), which represents 87.5% of the total number of screened 
colonies. To rule out Agrobacterium contamination, amplification with KanR gene-
specific primers only produced the expected 795 KanR gene in LBA4404 (positive 
control) but not in the seven putative NC64A transgenic lines (Figure 2.6b). The presence 
and absence of these gene-specific fragments in seven putative transgenic lines with no 
amplification product detected in non-infected wild-type NC64A indicated the successful 
transfer of both the hygromycin marker and the GFP-GUS reporter gene as a single T-





Figure 2.6. PCR analysis of putative NC64A transformants transformed with 
recombinant pCAMBIA1303 a064r domain 1. (a) Amplification of the 633 bp 
fragment of the a064r domain 1 gene fragment from four LBA4404 colonies post-
electroporation, and eight NC64A colonies after agro-mediation transfection. (b) 
Amplification of the KanR gene from LBA4404 (positive control) but not in the seven 
putative NC64A transgenic lines. (c) Transgenic NC64A colonies on selective media 
(containing 20 mg/L hygromycin and 500 mg/L cefotaxime). 
 
The identity of the PCR amplicons derived from transgenic NC64A colonies 
(Figure 2.6c) were further confirmed to be positive by DNA sequencing where sequence 
alignment showed 99 and 98% identity to the hpt and gfp-gusA genes in pCAMBIA1303 
respectively (Gene Bank accession no. AF234300). Visualization of GFP using a 
fluorescent microscope confirmed weak expression of the gfp gene in transformed cells 
as bright green fluorescence (Figure 2.7). The failure of many hygromycin-resistant 
colonies to produce any amplification product for either primer pair indicates the 











that were previously confirmed positive for a064r domain 1 by PCR could not be 
maintained or subcultured on hygromycin-supplemented media. No GUS-positive cell 
was detected in transgenic lines post-selection with hygromycin, although PCR 
amplification confirmed the presence of the gfp-gusA genes (data not shown). This may 





Figure 2.7. Transformation of NC64A with pCAMBIA1304 vector carrying the gfp–
gusA fusion reporter genes. Confocal fluorescent microscopy of live NC64A cells 
transformed with pCAMBIA1304 by Agrobacterium tumefaciens imaged with green, red, 
and GFP channels (from left to right). The GFP florescent channels shows the appearance 
of gfp expression. Bar represents approximately 5 m.  
 
In summary, a potentially simple method for Agrobacterium-mediated 
transformation of Chlorella variabilis NC64A was developed. Seven PCR-positive 
transformants were obtained, and the presence of the viral gene fragment suggests that 
the T-DNA was integrated into the genome; however, more extensive studies are needed 
to elucidate possible factors and mechanisms contributing to the loss of the gusA-gfp 
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expression. Other vector systems and/or promoters might also need to be tested on this 
microalga to develop a better transformation system. Nonetheless, the finding opens the 
possibility of further genetic manipulation of this commercially important microalga with 
















PBCV-1 PROTEINS A064R AND A061L TOGETHER HAVE FOUR 
TRANSFERASE ACTIVITIES INVOLVED IN GLYCAN SYNTHESIS 
3.1. OVERVIEW 
 
PBCV-1 encodes seven putative sugar manipulating enzymes with most of them 
predicted to be involved in the synthesis of its N-glycan(s) as disclosed by bioinformatic 
analyses [97, 111]: A064R (638 amino acids), A111/114R (860 aa), A219/222/226R (677 
aa), A473L (517 aa), A546L (396 aa), A071R (354 aa), and A075L (280 aa). However, 
this number is less than the 10 sugars present in the N-glycan attached to the MCP. 
Several possibilities could explain this discrepancy: 1) One or more of the seven putative 
GTases might have multiple functional domains, making this restricted repertoire of 
enzymes sufficient to synthesize these structures; 2) PBCV-1 genes encode enzymes that 
do not resemble GTases in the databases and, hence, they are not recognized during query 
searches; 3) a host-encoded GT(s) could contribute to the glycosylation process.  
Among the genes mentioned above, the protein coded by gene a064r is of interest 
because it is found in PBCV-1 but not in other chloroviruses where the glycan structures 
are known [51, 107, 206]. Also, experimental evidence shows that isolated spontaneous 
mutants (or antigenic variants) of PBCV-1 with mutations in a064r have truncated glycan 
structures [111, 113]. A combination of genetic and structural analyses suggested that the 
A064R protein has three putative domains of ∼200 amino acids each (SI Appendix, Fig. 
S1 [175]). Domain 1 (A064R-D1) was predicted to encode a β- L-rhamnosyltransferase 
and domain 3 (A064R-D3) was predicted to encode a S-adenosyl-L-methionine-
 94 
dependent MT (SAM)-dependent MT that decorates two positions in the terminal α-L-
Rha unit [111]. The A064R domain 2 (A064R-D2) was hypothesized to encode an α-L-
rhamnosyltransferase, despite only resembling bacterial proteins with unknown functions, 
thus, suggesting that it could be a new GT family.  
Here we provide evidence that the predictions about the three A064R domains are 
correct with the exception of A064R-D3, which adds only one methyl group and not two 
as proposed. It methylates O-2 of the α-L-Rha residue, while O-3 methylation is 
accomplished by another virus-encoded protein A061L.  
3.2. GLYCOSYLTRANSFERASE A064R AND METHYLTRANSFERASE A061L 
The chloroviruses are unusual because they are predicted to encode most, if not 
all, of the machinery to synthesize the glycans attached to their MCP. Here we show that 
two of the virus-encoded proteins A064R and A061L are functionally active. A064R has 
three domains: The first two are GTases and the third domain is a MT. A061L has a MT 
activity. The action of these two enzymes produce the fragment 2,3-di-O-methyl-α-L-
Rha-(1→2)-β-L-Rha, which is part of the complex N-linked glycan attached to the virus 
capsid protein. A064R domain 2 is a member of a new GT family. This provides direct 
evidence that the synthesis of PBCV-1 glycans are accomplished with virus-encoded 
enzymes.  
3.2.A. Materials and Methods 
Recombinant proteins. All recombinant proteins were expressed in E. coli cells. The 
A064R full-length protein was produced with a C-terminal 6xHis-tag (SI Appendix, Fig. 
S1 A and B [175]) using the pET23a vector as described [207]. Protein purification to 
homogeneity was performed using the Probond nickel-chelating resin (ThermoFisher, 
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code R801-01), following the manufacturer’s protocol. A064R domains (SI Appendix, 
Fig. S1 A and B [175]) were cloned and expressed in the pGEX-6P1 vector as described 
[207] obtaining fusion proteins with the glutathione S-transferase (GST) tag at the N 
terminus, that were purified using glutathione Sepharose 4B (GE Healthcare, code no. 
17–0756-01). The glutathione-Sepharose-bound proteins were used for the enzymatic 
reactions. Cleavage was achieved for A064R-D1 only by using Prescission protease (GE 
Healthcare, code no. 27–0843-01) on the column, and the released protein was 
concentrated using Amicon Ultra-4 (Millipore). The released domain was used for the 
UDP-GloTM assay. Purity of full-length A064R-6xHis protein and of the GST-fusion 
domains was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS/PAGE) and Coomassie blue staining (SI Appendix, Fig. S1C [175]). A061L protein 
(SI Appendix, Fig. S1 [175]) was cloned and expressed in pGEX-5X-1 expression vector 
(GE Healthcare), producing a GST tag at the N terminus of the target protein. The 
recombinant protein was purified on glutathione Sepharose as before and used for 
enzymatic reactions (more details in SI Appendix, Materials and Methods [175]). All 
eluted proteins were resolved by SDS/PAGE with Coomassie brilliant blue staining 
solution.  
Enzymatic reactions. All of the reactions were performed at 25 °C in phosphate buffer 
saline ([PBS]; Sigma-Aldrich, code no. P4417, composition: 0.01- M phosphate buffer, 
0.0027-M potassium chloride, and 0.137-M sodium chloride, pH 7.4) by using the 
enzyme still attached to the resin through its GST tag or it’s His tag in the case of the 
whole A064R. In a typical experiment, the reaction volume was about 150 μL and 
included 50 μL of resin (glutathione Sepharose 4B GE Healthcare or Probond nickel-
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chelating resin) with ∼250 μg of protein adsorbed unless otherwise specified. All 
enzymatic reactions were screened via high-pressure liquid chromatography (HPLC), 
using a C18 column (Phenomenex Kinetex 5 μ, 2,50 × 4.60 mm, code no. 00G-4601-E0) 
and 70% methanol as an eluent (flow rate at 0.8 mL/min) by injecting 10 μL of the crude 
reaction after centrifugation. For A064R-D1, the reaction was performed by using 
oligosaccharide 1 (1.5 mM) (Figure 3.1) as an acceptor and UDP-β-L-Rha (1.5 mM) as a 
donor in the presence of Mn2+ (2 mM). In order to verify the cation dependence of the 
enzyme, the reaction was repeated by adding EDTA (1 mM) to the protein 30 min prior 
to the addition of all of the other reagents except the cation. For A064R-D2, three 
different constructs were produced and tested: D2 (191–405 aa), D2L (191–438 aa), and 
D2L2 (213–438 aa). All three constructs were tested with oligosaccharide 2 (1.5 mM) as 
an acceptor and UDP-β-L-Rha (1.5 mM) and with or without cations (Mg2+ and Mn2+, 2 
mM). To exclude any cation dependency, a reaction with D2L was also tested by adding 
EDTA (0.5 mM), keeping the other reagents unchanged. The D2L reaction was repeated 
replacing acceptor oligosaccharide 2 with the L-Rha monosaccharide (1.5 mM). The resin 
with A064R-D1D2 was suspended in PBS buffer and incubated with oligosaccharide 1 
(1.5-mM), UDP-β-L-Rha (3.6 mM) and Mn2+ (2 mM). In the second reaction, 
oligosaccharide 6 (1.5 mM) was used instead of oligosaccharide 1, while all other 
components were kept unchanged. The resin with the full-length A064R attached was 
suspended with oligosaccharide 1 (1.5 mM), UDP-β-L-Rha (3.4 mM), the precursor for 
the MTs SAM (CAS no. 86867–01-8; code no. A7007, Microtech), and with both Mn2+ 
and Mg2+ (2 mM each). As for A061L, two reactions were performed by varying the 
nature of the acceptor. In the first reaction, oligosaccharide 3 (1 mM) was used as an 
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acceptor along with an excess of SAM (ca. 2 mM), Mn2+ and Mg2+ (2 mM each); in the 





Figure 3.1. (600 MHz and 310 K, D2O) 1H NMR spectra detailing the anomeric 
region of the oligosaccharides 1–7, drawn as a cartoon next to each spectrum. Each 
monosaccharide unit is labeled with a capital letter, and the full NMR attribution of each 
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compound is reported in the SI Appendix [175]. The peak at ca. 4.7 ppm is the residual 
solvent signal.  
 
Compounds isolation. The crude reaction solutions were centrifuged using spin columns 
with collection tubes (code no. H6787, Sigma-Aldrich) to remove the resin, and then, the 
pure products were recovered by C18 Sep-Pak cartridges (pore size 125 Å, particle size 
55–105 μm, code no. WAT051910, Waters) as detailed below. The Sep-Pak cartridge 
was activated with 10 mL of ethanol, 4 mL of acetonitrile, and 10 mL of water. After 
being loaded with the supernatant, the following elution was performed: 20 mL of water, 
15 mL of acetonitrile/water 1:4, 5 mL of acetonitrile, and 20 mL of ethanol. All fractions 
were dried and analyzed via NMR spectroscopy.  
Bioluminescent assay: UDP-GloTM assay. Two UDP standard curves were prepared in a 
96-well plate, performing a serial twofold dilution as described in the UDP-GloTM kit 
(code no. V6961, Promega), obtaining 12 solutions at different UDP concentrations. One 
reaction contained Mn2+ the other contained Mg2+ at the same concentration (40 mM). 
Thereafter, 25 μL of each solution was transferred to a second 96-well plate, and 25 μL 
of UDP detection reagent (provided by the UDP-GloTM kit) was added; the solutions 
were incubated at 25 °C for 1 h, and luminescence was measured with a luminometer. 
Reactions that involved the A064R-D1 enzyme, oligosaccharide 1 as an acceptor and 
UDP- β-L-Rha as a donor in separate phosphate buffer solutions (one with Mg2+ and the 
other with Mn2+), were performed maintaining a constant ratio of UDP-L-Rha/1 (2:1 
ratio; 2.470 and 1.250 nmol, respectively), while the GT amount decreased from the first 
solutions to the last where GT was absent. Similar to the UDP standard curves, the 
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solutions at different GT concentrations were obtained using twofold serial dilutions: 100 
μL of the GT solution (5 μL of GT 150 μg/mL; 5 μL Mn2+/or Mg2+, 40 mM; 4.75 μL PBS 
20×; 85.25 μL of water) was added in the first well followed by the addition of 50 μL 
buffer (composed of Mn2+/ Mg2+, 40 mM; PBS 20×, and H2O) to the additional 11 wells. 
Then, 15 μL from each well was transferred into 12 wells of another 96-well plate, and 
10 μL of the solution containing UDP-L-Rha (3.3 mM) and oligosaccharide 1 (1 mM) 
was added. The reactions were incubated at 25 °C for 1 h, after that 25 μL of the UDP-
detection buffer was added to each well, and the solutions were kept at the same 
temperature for one additional hour prior to measuring luminescence. Two replicas for 
each experiment were performed. The same strategy was used for the following two 
reactions, in which the activated sugar donor or the acceptor substrate were changed, 
maintaining the 2:1 ratio as before: in one, the UDP-L-Rha was substituted with the UDP-
D-Glc (10 mM), and in the other, the D-Xyl monosaccharide (1 mM) was used instead of 
oligosaccharide 1. Experiments were performed in the presence of both bivalent cations. 
Luminescence measurements were performed with a Synergy HT multimode microplate 
reader (BioTek instrument) using a 96-well microplate with standard 128 × 86-mm 
geometry with an integration time of 1.0 s. Luminescence was measured by a low-noise 
photomultiplier detector through an empty filter position in the emission filter wheel. 
Data analysis and the construction of the graphs were achieved with Excel Software.  
NMR spectroscopy. All NMR experiments of the oligosaccharides from 1 to 7 in Figure 
2 were recorded in D2O at 310 K on a Bruker DRX-600 MHz (1H: 600-MHz and 13C: 
150-MHz) instrument equipped with a cryoprobe except for the Rha disaccharide for 
which a temperature of 298 K was used. All chemical shifts are referred to internal 
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acetone (1H 2.225 and 13C 31.45 ppm). The set of 2D spectra (correlation spectroscopy, 
TOCSY, T-ROESY, and HSQC) were measured for each substrate, except for 
oligosaccharides 3, 7, and the α-L-Rha-(1→2)-L-Rha disaccharide for which only the 
heteronuclear single quantum correlation (HSQC) and the total correlation spectroscopy 
(TOCSY) experiments were acquired and for structures 1 and 2 where HMBC was also 
recorded. Homonuclear experiments were recorded using 512 free induction decays 
(FIDs) of 2,048 complex data points, setting 24 scans per FID for all experiments, 
whereas for structures 3 and 4, 32 scans per FID were set in order to obtain a better signal 
to noise ratio. Mixing time of 100 ms was applied for TOCSY and 300 ms for T-ROESY 
spectra acquisitions. 1H-13C heteronuclear experiments were acquired with 512 FIDs of 
2,048 complex points with 40–80 scans per FID, depending on the sample abundance. 
Standard Bruker software Topspin 3.1 was used to process and analyze all spectra. NMR 
operating conditions used for the characterization of the synthetic intermediates of 
oligosaccharides 1 and 6 are reported in the SI Appendix [175].  
Phylogenetic analyses. Multiple sequence alignment and phylogenetic reconstructions 
were performed using the Environment for Tree Exploration3 (ETE3) v3.1.1 program 
[208] as implemented on the GenomeNet (https://www. genome.jp/tools/ete/). 
Phylogenetic trees were constructed using maximum likelihood and neighbor-joining 
approaches using PhyML v20160115 ran with model pa- rameters: -f m–pinv e -o tlr–
nclasses 4–bootstrap 100–alpha e [209]. The branch supports are the χ2-based parametric 
values return by the approximate likelihood ratio test. Maximum-likelihood annotation 
was generated by Interactive Tree of Life (iTOL) [210]. Viral proteins were used as 
queries to search the publicly available NCBI nonredundant sequence database using 
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BLASTp and hits filtered based on general parameters excluding chloroviruses. The 
characterized GT domains were identified using UniProt [211] and HHpred [212] from 
selected rhamnosyltransferases in the CAZy database.  
Protein modeling. PBCV-1 A064R-D3 and A061L structure predictions were 
constructed by Phyre2 [213]. Molecular docking of viral proteins complexed with SAM 
were performed using PatchDock [214], an algorithm based on shape complementarity 
principles. Protein complexes were inputted into the molecular modeling system, 
Chimera where 3D protein models were con- structed. SAM-binding residues were 
generated by SAMbinder [215, 216]. Final drawings and residue analysis were prepared 
with molecular graphics system PyMol, a molecular graphics system, Version 1.2r3pre, 
Schrödinger, LLC.  
Data availability. All study data are included in the article and supporting information 
and the UniProt Knowledgebase (UniProtKB), https://www. uniprot.org/ (accession no. 
A0A516L7Y9).  
3.2.B. Results and Discussion 
A064R-D1: β-L-Rhamnosyltransferase activity. A064R-D1, amino acid residues 1–212 
in the PBCV-1 A064R protein (SI Appendix, Fig. S1A [175]) was originally predicted to 
be a GT in subfamily 34 (GT34; retaining) [217]. Thereafter, A064R-D1 was expressed 
as a recombinant protein and crystallized confirming it to be a member of the GT34 
subfamily and preferring uridine 5′-diphosphate (UDP)-Glc as a donor substrate. 
However, this study occurred before the PBCV-1 glycan structure(s) was known, and this 
first hypothesis was later refuted by Speciale et al. [111] who predicted that A064R-D1 
added L-Rha to D-Xyl.  
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Here, we biochemically evaluated this prediction by using the tetrasaccharide 1 
(Figure 3.1) as the acceptor substrate. This oligosaccharide is a simplified truncated 
version of the N-glycan from PBCV-1 in which the D-Xyl is available for glycan 
elongation. In contrast to the natural glycan, the Fuc in 1 is capped at the reducing end 
with an octyl group (Figure 3.1 and SI Appendix, NMR Characterization, Figs. S2 and 
S3, and Table S1 [175]), facilitating the monitoring of the reaction via HPLC and the 
purification of the products. UDP- β-L-Rha was used as the donor, and the reaction was 
monitored by either the HPLC or by the UDP-GloTM assay. When the reaction mixture 
included Mn2+, the HPLC profile (Figure 3.2) showed the formation of pentasaccharide 2 
while oligosaccharide 1 simultaneously decreased. NMR analysis of oligosaccharide 2 
revealed an additional signal at 4.79 parts per million (ppm), labeled E, in the anomeric 
region (Figure 3.1). Comparison of the HSQC spectrum of oligosaccharide 2 (SI 
Appendix, Fig. S4 [175]) with that of oligosaccharide 1 identified the three common 
residues: namely, A (2,3,4-substitued α-L-Fuc), B (terminal α-D-Gal), and C (terminal α-
D-Rha). The β-D-Xyl unit (D) showed some chemical shift variations because of 
glycosylation at O-4 as inferred by the downfield displacement of the corresponding 
carbon chemical shift (79.4 ppm, SI Appendix, Table S2 [175]) compared to the 
reference (70.7 ppm as found in 1, SI Appendix, Table S1 [175]).  
As expected, the newly added residue in oligosaccharide 2 was a β-L-Rha (E) 
linked at position 4 of D-Xyl (D) as proven by the diagnostic correlations found in both 
heteronuclear multiple bond correlation (HMBC) and T-ROESY spectra (SI Appendix, 
Figs. S4 and S5B [175]). The β-configuration of this anomeric center was inferred by the 
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diagnostic nuclear Overhauser effect (NOE) contacts between the anomeric proton H-1 of 
E with its H-3 and H-5 protons and confirmed by the 1JC,H value (160.3 Hz).  
To demonstrate the importance of the cation, the same reaction was repeated 
without Mn2+ along with EDTA; the HPLC profile (SI Appendix and Fig. 3B [175]) 
revealed that the enzyme required Mn2+ to function. Together, these results establish that 
A064R-D1 acts as a Mn2+-dependent β-L-rhamnosyltransferase, able to form the β-L-
Rha-(1→4)-β-D-Xyl linkage. Moreover, the complete conversion of the substrate attests 
to a lack of a relevant hydrolytic activity versus the donor under the conditions tested, 
similar to what is observed for the other enzymes (A064R-D2 and A064R-D1D2).  
These results were confirmed by the bioluminescent UDP-GloTM assay in which 
the specificity of the enzyme for Mn2+ and Mg2+ was tested, disclosing the enzyme’s 
affinity for Mn2+ (SI Appendix, Fig. S6A [175]), in agreement with previous studies 
[217]. The nature of the acceptor and donor substrates was also investigated, leading to 
further information (SI Appendix, Fig. S6B [175]): 1) The enzyme did not recognize 
UDP-α-D-Glc, in agreement with our previous prediction and contrary to previous studies 
[217]; and 2) the enzyme recognized D-Xyl alone as an acceptor, albeit with a lower 





Figure 3.2. A064R-D1 demonstrates β-L-Rhamnosyltransferase activity. HPLC 
chromatographic profiles obtained from the reaction of the A064R-D1 enzyme 
(schematic at the bottom indicating its length in aa) with tetrasaccharide 1 (acceptor) and 
UDP-β-L-Rha (donor) in the presence of (a) Mn2+ and (b) with EDTA and without 
cations. Peak labels refer to oligosaccharide structures in Figure 3.1. 
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A064R-D2: α-L-Rhamnosyltransferase activity. We previously predicted that A064R-
D2 adds the second L-Rha to the first L-Rha [97, 111]. To test this prediction, three 
versions of the second domain were designed by changing the boundaries, cloned and 
tested (SI Appendix, Fig. S1A [175]). The first construct (215 aa; named D2) was based 
on bioinformatic studies. The other two constructs included 33 additional amino acids at 
the C terminus and differed in length of the N-terminal region: D2L (aa 191–438) and 
D2L2 (aa 213–438).  
C-terminal elongation was investigated because the antigenic variant CME6 [111] 
has a functional D2 domain longer than the bioinformatic prediction. The first 17 amino 
acids of the N-terminal region were omitted in the D2L2 construct because they were 
predicted to form a flexible loop and, therefore, unlikely required for activity. The three 
proteins were screened for activity using pentasaccharide 2 (Figure 3.1) as an acceptor 
and UDP-β-L-Rha as a donor with or without cations (Mg2+ or Mn2+). Interestingly, the 
construct initially developed from the bioinformatic studies (D2) was not active (SI 
Appendix, Fig. S7A [175]), while the other two D2L and D2L2 produced the 
hexasaccharide 3 (SI Appendix, Fig. S7 B and C [175]).  
The same reaction occurred with the D2L enzyme after five days of storage at 4 
°C indicating that the enzyme was still active (SI Appendix, Fig. S7D [175]). 1H-NMR 
spectroscopic investigation showed that oligosaccharide 3 had an additional anomeric 
signal (5.03 ppm, labeled F) compared to 2 (Figure 3.1). Comparison of the HSQC 
spectra of 2 and 3 (SI Appendix, Fig. S8A [175]) identified L-Fuc (A), D-Gal (B), α-D-
Rha (C), and D-Xyl (D), while the chemical shifts of β-L-Rha (E′) were slightly different 
due to its glycosylation at C-2, (78.1 ppm instead of 71.8 ppm, SI Appendix, Table S3 
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[175]). The new unit F was a terminal α-L-Rha; its anomeric signal showed only one 
correlation in the TOCSY pattern (SI Appendix, Fig. S8B [175]) ascribed to the H-1/H-2 
cross peak, whereas the connections up to the methyl group H-6 (1.30 ppm) were visible 
from H-2, while the C-5 chemical shift value at 69.7 ppm supported the α-configuration 
of this residue [218].  
These results establish that A064R-D2 is an inverting GT, that forms the α-L-Rha-
(1→2)-L-Rha linkage. Moreover, amino acids 191–212 at the N terminus do not 
contribute to the functionality of the protein, but the 33 extra amino acids at the C 
terminus in D2L2 and D2L are crucial for activity. It is possible that these residues are 
involved in some dynamic interaction that enables the proper protein folding or confers 
stability. The reaction was cation independent as confirmed by adding EDTA to the 
mixture (SI Appendix, Fig. S7E [175]).  
Two additional experiments were performed to learn more about the substrate 
specificity of A064R-D2. First, the octyl xyloside 6 (Figure 3.1) was used as the acceptor 
with the D2L construct, and no reaction occurred (SI Appendix, Fig. S7F [175]). Next, 
the reaction was performed using L-Rha monosaccharide as the acceptor. In this case, the 
reaction could not be monitored via HPLC, but NMR analysis after overnight incubation 
revealed the formation of a α-L-Rha-(1→2)-L-Rha disaccharide. The 1H-NMR spectrum 
of the product differed from those of the reagents Rha and UDP-Rha (SI Appendix, Fig. 
S9A [175]), and the HSQC spectrum (SI Appendix, Fig. S9B [175]) displayed two 
anomeric signals at 1H/13C 5.22/93.7 ppm and 4.96/103.3 ppm related to the two-linked 
α-L-Rha at the reducing end (R) and to the terminal α-Rha (T), respectively (SI 
Appendix, Table S4 [175]). The NMR analysis (SI Appendix, Fig. S9 B and C [175]) 
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confirmed the identity of the disaccharide. In particular, the downfield shift of the C-2 
carbon signal of residue R (to 80.3 ppm), confirmed its glycosylation and showed that the 
enzyme was able to link α-L-Rha at O-2 to another L-Rha unit. A detailed inspection of 
the spectra detected trace amounts of disaccharide α-L-Rha-(1→2)-β-L-Rha, as well.  
Thus, D2L recognizes free Rha as an acceptor. Based on the structure of 
oligosaccharide 2, which has a β-Rha, we hypothesize that the β-anomer of Rha is the 
substrate of the enzyme not the α-anomer. Once formed, the reducing end of the 
disaccharide is converted by mutarotation into the predominant α-form, while some of the 
free α-Rha replaces the β-form that was consumed. This β-form then reacts with the 
enzyme and additional UDP-β-L-Rha to give the disaccharide, and this process continues 
up to the total consumption of the monosaccharide. This hypothesis needs to be validated 
by future work. Because A064R-D2 resembles several proteins with unknown functions 
in the GenBank, we predict that these homologs are likely to be undiscovered GTases. 
Thus, A064R-D2 is a new cation- independent inverting GT that can interact with 
different Rha-containing molecules.  
A064R-D1D2 activity. To confirm our previous findings and expand our understanding 
about A064R-D1 and A064R-D2 activities, two additional experiments were performed. 
We made a recombinant protein, A064R-D1D2 (aa 1–438), similar to that encoded by the 
antigenic variant CME6 virus [111], comprising D1 and D2L active domains. The first 
reaction used tetrasaccharide 1 as an acceptor and two equivalents of UDP-L-Rha and 
Mn2+; formation of hexasaccharide 3 was almost complete after 2 h (SI Appendix, Fig. 
S10A [175]).  
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The other acceptor used was monosaccharide 6 (Figure 3.1) which disclosed that 
A064R-D1D2 worked also with a different D-Xyl source. The chromatographic profile 
after 2 h showed that oligosaccharide 6 was replaced with trisaccharide 7 (SI Appendix, 
Fig. S10B [175]), whose identity was confirmed by NMR analysis (Figure 3.1 and SI 
Appendix, Fig. S11, chemical shifts in SI Appendix, Table S5 [175]), namely, that it was 
6 with the α-L-Rha-(1→2)-β-L-Rha disaccharide attached to O-4 of the Xyl unit as 
expected.  
A064R-D1 and A064R-D2 bioinformatic analysis. Phylogenetic analysis of annotated 
GT domains from characterized rhamnosyltransferases revealed that the A064R-D1 was 
more like members in the GT1 family rather than the GT2 family (Figure 3.3a, detailed 
list of the organisms used in SI Appendix, Table S6 [175]). However, a previous crystal 
structure of A064R-D1 indicated a structural fold similar to catalytic domains of retaining 
GTases in the GT-A family (characterized by a N-terminal Rossmann-like fold) [217], 
although the amino acid sequence similarity was very low (less than 14% for equivalent 
Cα atoms), further validating its separation from other characterized 
rhamnosyltransferase proteins. An A064R-D1 pBLAST query search shows the highest 
sequence similarity to hypothetical proteins from bacteria and a galactosyl transferase 
domain from Burkholderia.  
Interestingly, A064R-D1 shares an ancestral node of origin with eukaryotic 
homologs (SI Appendix, Fig. S12A [175]). Interestingly, A064R-D2 is the most unusual 
of the three A064R domains because it least resembles a recognizable GT. Its lack of 
sequence homology with annotated rhamnosyltransferases (<30% with only 15% 
coverage) makes it an outlier in a phylogenetic analysis that groups more closely with 
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other GT2 family members rather than GT1s in the phylogenetic tree (Figure 3.3a). We 
used BLASTp to further evaluate A064R-D2 (aa 213–439, SI Appendix, Fig. S1A [175]). 
This domain shares limited homology with several hypothetical and uncharacterized 
proteins from bacteria, including one GT-family protein from Lacipirellula parvula 
(31.36% identities with 95% coverage) and two homologs in Pithovirus: a hypothetical 
protein and a GT10 fucosyltransferase (>45% and >35% identities covering the C-
terminal domain, respectively). The majority of A064R-D2 homologs are of bacterial 










Figure 3.3. Maximum-likelihood phylogenetic trees of some PBCV-1 encoded 
proteins involved in glycan synthesis. Phylogenetic trees are shown for GT-associated 
domains from (a) characterized rhamnosyltransferases and (b) selected MTases. (a) Tree 
construction is based on GT-associated domains of virus-encoded rhamnosyltransferases 
A064R-D1, A064R-D2, and a variety of annotated rhamnosyltransferases from CAZy. 
(b) Tree construction is based on MT homologs of virus-encoded proteins A064R-D3 and 
A061L. The branch lengths indicate evolutionary distance and are labeled with (a) 
organism, residue range of GT domain, and GT family (a); and organism (b). PBCV-1 
encoded proteins are in bold. The list of the organisms used along with their UniProtKB 
gene accession nos. is reported in SI Appendix, Table S6 [175].  
 
A064R-D3: SAM-Dependent methyltransferase activity. A064R-D3 (aa 439–638) is 
predicted to have SAM-dependent MT activity. An A064R-D3 pBLAST query search 
shows the highest sequence similarity to several hypothetical proteins from bacteria and 
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many class I SAM-dependent MTases of both bacteria and virus origins (SI Appendix, 
Fig. S13A [175]). Therefore, we previously hypothesized that it might add the two 
methyl groups to the terminal L-Rha of the glycan [111]. To address this hypothesis, we 
used the complete A064R protein because the third domain by itself did not form a 
soluble recombinant protein.  
Hence, A064R was incubated with 1 as the acceptor and with two equivalents of 
UDP-β-L-Rha with Mn2+ and Mg2+ as the cation requirement of this domain was 
unknown. Due to the labile nature of SAM, it was not possible to add two equivalents 
with certainty, thus, we repeatedly added SAM until no increase in new products 
occurred as judged by HPLC. The reaction produced two products (SI Appendix, Fig. 
S14A [175]). The less abundant one was hexasaccharide 3 as established by its retention 
time and by NMR analysis of the mixture. The NMR analysis of the most abundant 
product 4 (Figure 3.1 and SI Appendix, Fig. S14 B and C and Table S7 [175]) revealed 
that methylation only occurred at O-2 of the terminal α-L-Rha residue not at both O-2 and 
O-3 as hypothesized.  
1H-NMR and HSQC spectra of oligosaccharide 4 (Figure 3.1 and SI Appendix, 
Fig. S14 B and C [175]) revealed the same residues found in oligosaccharide 3 with H-1 
of E (here, labeled E′′) slightly shifted and a new anomeric signal at 5.17 ppm, labeled as 
F′, which instead replaced F. The anomeric proton of F′ had the TOCSY pattern typical 
of a Rha unit, α-configured based on its C-5 value (69.5 ppm) and methylated at O-2 
based on the diagnostic value of C-2 (81.2 ppm). This finding was confirmed from the 
NOE contact between H-2 of F′ with the methyl group at 3.45 ppm in the T-ROESY 
spectrum, which also reported that F′ was linked to O-2 of E’’ (SI Appendix, Fig. S14C 
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[175]). This reaction established that the third domain of A064R only added one methyl 
group to the C-2 hydroxyl group of the terminal α-L-Rha, leaving open the question about 
what enzyme methylated the C-3 hydroxyl group.  
A061L: Methyltransferase activity. To determine the enzyme responsible for adding a 
methyl group to O-3 of the terminal α-L-Rha residue, we screened the PBCV-1 genome 
for another gene encoding an O-MT. This led to the discovery of the gene a061l (SI 
Appendix, Fig. S1A [175]). Phylogenetically distinct from A064R-D3 (Figure 3.3b), the 
closest homolog of A061L is a macrocin-O-MT from Dishui Lake large algae virus 1. An 
A061L pBLAST query search shows the highest sequence similarity to several well-
characterized class I SAM-dependent MTases from bacteria and, although more distantly 
related, from cyanobacteria and algae (SI Appendix, Fig. S13B [175]). Moreover, it had a 
structural homology of 90% of the sequence modeled with 100% confidence with the O-
MT NovP from Streptomyces spheroids.  
Recombinant A061L was tested for activity using hexasaccharides 3 or 4 as 
acceptors, SAM as a donor of the methyl group, and with both Mg2+ and Mn2+. The two 
acceptors differed only in the presence of the methyl group on O-2 of the terminal L-Rha 
(Figure 3.1). A061L only methylated hexasaccharide 4, the substrate with the terminal L-
Rha already possessing a methyl group at O-2 (SI Appendix, Fig. S15 [175]). No reaction 
occurred with the unmethylated hexasaccharide 3. The structure of product 5 was inferred 
via NMR spectroscopic analysis (SI Appendix, Fig. S16 and Table S8 [175]) which 
confirmed the presence of two methyl groups (at O-2 and O-3) on the terminal L-Rha 
unit. This last experiment demonstrated that the virus-encoded A061L added a methyl 
group to the O-3 of the terminal L-Rha only when it was already methylated at O-2. 
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However, it remains unclear if it has a cation requirement. Additional experiments will be 
performed to better define all of the characteristics of this enzyme.  
Modeling the two methyltransferases. The MT activity of A064R-D3 was supported by 
bioinformatic information; the protein has 31.5% identity with 91% coverage (3e−19 
confidence value) with a protein coded by a prokaryotic dsDNA virus sp. (UniProtKB 
gene accession no. A0A516L7Y9). This viral gene encodes a putative 8-demethyl-8-α-L-
rhamnosyl tetraceno-mycin-C2′-O-MT (Figure 3.3b). Moreover, a protein structure 
prediction by Phyre2 analysis chose the SAM/metal-dependent O-MT MycE from 
Micromonospora griseorubida to predict the 3D structure of A064R-D3 based on 178 
residues (89% of the sequence modeled with 100% confidence). The choice by Phyre2 to 
use this particular MT is consistent with our results.  
Previously, crystal structures were determined for MycE bound to the product S-
adenosyl-L-homocysteine (SAH) and Mg2+, the first structure of a natural product sugar 
MT in complex with its natural substrate [219]. The structure of A064R-D3 (aa 446–638) 
is predicted to accurately trace the catalytic MT domain of MycE (aa 161–399) from 
residues 161–340 situated in the C terminus comprising an α/β-sandwich with a seven-
stranded β-sheet core sandwiched by three α-helices on the front face and two on the 
back. In agreement with other class I MTases, A064R-D3 possesses a series of conserved 
motifs shared among these proteins, named motifs I–VI [220].  
Notably, A064R-D3 residues 43–51 (Ile43, Ile44, Glu45, Ile46, Gly47, Ile48, 
Gly49, Asp50, and Phe51) resemble motif I, a nine-residue amino acid block with the 
consensus sequence (V/I/L)(L/ V)(D/E)(V/I)G(G/C)G(T/P)G. This nine-residue structure 
contains the glycine-rich ‘‘GxGxG’’ signature sequon, a SAM-binding motif found in 
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almost all SAM-dependent MTases. Prediction of the A064R-D3 SAM-binding sites was 
corroborated by the enzyme-ligand structure model (Figure 3.4a and 3.4b). Residues 
positioned within 5 Å of the SAM ligand are organized into three major regions: 46–51, 
74–81, and 121–124. The predicted SAM- binding site for A064R-D3 is located within 
the loops at the C-terminal end of the central β-sheet as usually occurs for methyl- 
transferases. Prediction models detect coordination of a metal ion by homologous 
residues Asp121, Glu149, and Asp150 in accord with the metal dependence of activity 
observed in MycE (Asp275, Glu303, and Asp304). These residues are strictly conserved 
among the MycE homologs, implying that all homologs are metal dependent. The SAM 
amino acid moiety contacts Asp18 through the carboxyl group and with Asp121 and 
Asp150 through the amino group. As for the metal ligands, the residues that contact SAM 
are highly conserved. Protein sequence alignment of A064R-D3 and MycE displays 
homology in critical functional residues (SI Appendix, Fig. S17 [175]). In total, A064R-
D3 has 12 of the 23 SAM-binding residues with MycE. Furthermore, active site residues 
Tyr208 and His278 determined in MycE have homology with A064R-D3 residues Phe51 
and His124. The single-residue substitution Y208F MycE resulted in reduced but not 
abolished enzyme activity [219].  
Phyre2 analysis of the SAM/metal dependent sugar O-MT NovP from S. 
spheroides allowed the prediction of the 3D structure of A061L based on 188 residues 
(modeled with 100% confidence). The A061L sequence contains recognizable motifs I 
and II that are typical of SAM-dependent MTases (SI Appendix, Fig. S18 [175]). Motif I 
lies between β1 and α4 and forms the expected interactions with the amino acyl portion 
of SAM via Glu21 and Gly23, equivalent to residues Glu92 and Gly94 in NovP. Motif II, 
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defined as an acidic loop, which lies at the C-terminal end of β2, forms the expected 
interactions with the ribose hydroxyls groups via Asp50, equivalent to residue Asp122 in 
NovP. The active center of NovP contains a strictly conserved metal-binding site 
composed of three Asp residues: Asp196, Asp223, and Asp224 [221]. A further 
conserved Asp198 likely acts as the general base that initiates the methyl transfer 
reaction. Using in silico docking, we generated models of the A061L-SAM complex that 
are consistent with this mechanism (Figure 3.4c and 3.4d). A061L possesses a 
homologous three Asp sequence (Asp143, Asp170, and Asp171) and a general base 
Asp145, the putative general base of the reaction, is well con- served in A061L structural 
homologs. We propose this residue initiates the methyl transfer reaction by deprotonating 







Figure 3.4. Stereoviews showing superpositions of methyltransferases A064R- D3 
and A061L with structural homologs. (a) Superposition of predicted A064R-D3 
(green) complexed with SAM (cyan) with crystalized SAM/metal-dependent sugar O-MT 
MycE chain E (gray) from M. griseorubida in complex with Mg ion (magenta) and SAH 
(gray). (b) Magnified view of the predicted A064R-D3 SAM-binding site. (c) 
Superposition of predicted A061L (orange) complexed with SAM (cyan) with crystalized 
SAM/metal-dependent sugar O-MT NovP chain A (gray) from S. spheroids in complex 
with sulfate ion (red and yellow) and SAH (gray). (d) Magnified view of the predicted 
A061L SAM-binding site. Residues represented by stick models are predicted to be 
positioned within 5 Å of the SAM ligand and have the equivalent residue position of 



















predicted to bind SAM or metal ion via hydrogen bonding or participate in polar contact. 
Bound SAM and SAH are represented by stick models. 
 
3.2.C. Conclusions 
To date, the evidence indicates that chloroviruses decorate their MCP with 
atypical N-glycans [51, 107, 206] and that the viral genome encodes most, if not all, of 
the enzymes responsible for synthesizing these glycans. These results support this 
hypothesis by defining the activity of protein A064R, one of the GTases encoded by 
chlorovirus PBCV-1, along with the function of the A061L protein encoded by another 
gene a061l.  
A064R (638 aa) has three functional domains of ∼200 aa each. The first two are 
GTases, and the third is a MT that methylates O-2 of the terminal α-L-Rha residue. The 
finding that the third domain only transfers one methyl group prompted the search for a 
second virus-encoded MT, which led to the identification of A061L. This enzyme 
completes the methylation of the terminal α-L-Rha by adding a methyl group to its O-3 
position but only after the O-2 position has been methylated.  
From a structural viewpoint, a064r encodes a rare protein because it has three 
functional transferase activities: two different rhamnosyltransferases and one MT. To 
date, few enzymes with multiple GT activities have been identified, and most of them 
only have two functions. The oldest is KpsC, an enzyme with two GT activities that are 
involved in the biosynthesis of the E. coli K5 polysaccharide [222]. More recently, 
Clarke et al. [223] discovered an O2a polymerase (WbbM) in Klebsiella pneumoniae that 
possesses two domains, a galactopyranosyltransferase resembling known GT8 family 
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enzymes and a galactofuranosyltransferase defining a previously unrecognized family 
(GT111). Only a few other multidomain enzymes have been identified with more than 
one GT active site: WbdA mannosyltransferase involved in the synthesis of the E. coli 
O9, O9a, and O8 lipopolysaccharide O antigens, which is recognized as a bifunctional α-
(1→2)-, α-(1→3)-mannosyltransferase in serotype O9a, while its counterpart in serotype 
O8 is a trifunctional mannosyltransferase (α-[1→2], α-[1→3], and β-[1→2]) [224, 225]. 
Analyses on the O-antigenic polysaccharide produced by some isolates of Raoultella 
terrigena and K. pneumoniae identified another trifunctional GT protein (WbbB), which 
is able to generate a polysaccharide of [4)-α-Rha-(1→3)-β-GlcNAc-(1→] repeating units 
capped with a nonreducing terminal residue of β-linked 3-deoxy-D-manno-oct-2-ulosonic 
acid (β-Kdo) [226]. Other bifunctional microbial GTases are those involved in the 
biosynthesis of glycosaminoglycans and glycosaminoglycan-like polysaccharides, such 
as those involved in synthesis of hyaluronan [227], including one from PBCV-1 [99], 
chondroitin [228], and heparosan [229], along with KpsC from E. coli K5, mentioned 
above. The dGT1 enzyme from Streptococcus parasanguinis is a bifunctional protein 
involved in the biosynthesis of the serine-rich repeat protein adhesin Fimbriae associate 
protein (Fap1), which is essential for glycosylation of Fap1 [230]. Thus, A064R is part of 
a restricted pool of GTases with three activities with the qualifier that the third domain is 
a MT.  
Our analysis leads to several significant conclusions: 1) PBCV-1 and probably 
other chloroviruses encode multifunctional proteins involved in glycan synthesis of their 
MCP glycoproteins; 2) the PBCV-1 protein A064R possesses a domain (D2) that may 
represent a new GT family; 3) the A064R protein and probably other chlorovirus encoded 
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GTases are likely to be soluble due to the lack of N-terminal signal peptides that target 
them to the ER or the Golgi. This last conclusion suggests they may be easier to express 
and purify.  
Beyond the significance of our findings to chlorovirus biology, we can imagine 
employing this protein or its individual domains for other purposes, e.g., the A064R-
D1D2 protein could be used to produce a different class of rhamnolipid biosurfactants, 
having the rhamnobiose unit attached to an alkyl xyloside. Rhamnolipids are primarily 
produced from some strains of Pseudomonas [231] and have multiple uses and properties 
as active agents in skin re-epithelialization in wound healing [232] or used in the 
cosmetics field for the treatment of wrinkles or to alleviate and/or prevent immunological 
activities associated with autoimmune diseases.  
In conclusion, the results described herein provide direct evidence that the 
synthesis of the PBCV-1 N-glycan, or, at least, part of it, is accomplished with enzymes 
encoded by the virus itself. This finding is particularly relevant as it subverts the dogma 





PBCV-1 PROTEIN A111/114R HAS THREE GLYCOSYLTRANSFERASE 
ACTIVITIES INVOLVED IN GLYCAN SYNTHESIS 
4.1. OVERVIEW 
Interestingly, all the chloroviruses studied to date, including those with different 
host specificities, have the capsid protein N-glycosylated with other types of 
oligosaccharides; however, all chloroviruses share the same pentasaccharide core 
oligosaccharide [51, 206] composed of an N-linked Glc, a hyperbranched Fuc, a distal 
and a proximal Xyl, and a Gal (Figure 1.10). Additional monosaccharides decorate this 
core N-glycan, producing a molecular signature for each chlorovirus [107]. This 
oligosaccharide core was also found in all mutants (or antigenic variants) of PBCV-1 
analyzed to date, except for PIL6 [111]). Mutant PIL6 is a representative of the antigenic 
class D, characterized by a large genomic deletion spanning genes a014r through a078r 
[111, 233]. Its N-glycan is a tetrasaccharide and is significantly truncated compared to that 
of wild-type PBCV-1. It contains all the units of the chloroviruses N-glycans present in the 
conserved core region except the distal Xyl attached to Fuc [107]. By analyzing the 
genomes of all chloroviruses and of the mutants sequenced to date, we noted that the 
a111/114r gene is the only annotated orthologous GT gene found outside of the region of 
the large deletion mutants that is present in all other chloroviruses. This finding suggests its 
likely involvement in the synthesis of the initial part of the unusual N-glycan shared by all 
of these viruses and prompted us to investigate its role in the assemblage of the conserved 
core oligosaccharide. 
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4.2. GLYCOSYLTRANSFERASE A111/114R 
To predict the A111/114R protein structure and functions, we used a combination 
of genetic and structural analyses, together with hydrolytic activity assays and in silico 
evidence by sequence analysis and protein modeling. The combined results suggest that 
the A111/114R protein is a multi-domain/multi-functional GT likely involved in the 
attachment of three of the five monosaccharides in the conserved core region of the N-
glycan (Figure 1.10). Specifically, this large protein of 860 amino acids is comprised of 
three putative domains (Figure S1 [234]; Figure 4.1), each with a specific role; the N-
terminal domain (1–260 aa) is a galactosyltransferase, the central domain (261–559 aa) is 




Figure 4.1. Predicted GT domains of PBCV-1 encoded protein A111/114R. 
A111/114R domain analysis based on remote homology identified three putative GT 






to 559 aa), and C-terminal (560 to 860 aa) regions, respectively. Below individual 
domains are the corresponding three-dimensional protein models assigned by Phyre2 
[235] based on alignments to known protein structures identified by their PDB entry: 
1GA8 Chain A (D1), 2Z86 Chain D (D2), 2NZY Chain A (D3). Protein ribbon models 
are rendered using rainbow colors from N-terminus (blue) to C-terminus (red). The 
putative domain, predicted protein model, and sugar substrate are connected by the black 
dashes. 
 
4.2.A. Materials and Methods 
Protein modeling. The prediction of the different domains of A111/114R was performed 
by HHpred [236] based on remote homology detection. Then, the 3D model of each 
domain was built by Phyre2 (Protein Homology/analogY Recognition Engine V 2.0) in a 
normal mode [235]. Each 3D model was based on an alignment generated by HMM–
HMM matching. Final drawings and residue analysis were prepared with the molecular 
graphics system PyMol Version 1.2r3pre, Schrödinger, LLC. 
Cloning and expression. PBCV-1 a111/114r and domain variants were cloned from 
PCR-amplified viral DNA using oligonucleotide primers with restriction sites NotI–
BamHI. PCR fragments of the expected size were digested and inserted into the 
restriction sites of the pMAL-c6T expression vector (New England Biolabs, Ipswich, 
MA, USA). This process produced a maltose-binding protein (MBP) tag at the N-
terminus of the target protein. The resulting plasmid was transformed into E. coli strain 
One Shot TOP10 competent cells (Invitrogen) for maintenance. The E. coli cells 
containing positive cloned plasmids were selected with 100 μg/mL carbenicillin. The 
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cloned structure of each vector was sequence verified. Plasmids were isolated with a 
QIAprep Spin Miniprep kit (Qiagen, Valencia, CA, USA) according to the 
manufacturer’s instructions and transformed into NEBExpress competent cells for 
expression. Viral genes were expressed by growing cells overnight at 37 °C in 10 mL of 
LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L sodium chloride) containing 100 
μg/mL carbenicillin. Then, 5 mL of the over-night culture was sub-cultured into 200 mL 
LB medium containing 100 μg/mL carbenicillin. The batch culture was grown to an 
OD600 of 0.6 at 37 °C and then induced with 0.1 mM IPTG and incubated at 16 °C 
overnight. The cells were harvested by centrifugation at 3500× g, for 5 min at 4 °C, and 
resuspended in 35 mL of PBS with 2 mM phenylmethylsulfonyl fluoride (PMSF). After 
incubation on ice for 30 min, cells were disrupted by sonication for 3 min using a Tekmar 
sonic disruptor at 30% amplitude, in 5 s pulses. Samples were centrifuged at 10,000 rpm 
for 15 min to separate soluble and insoluble fractions. 
Purification of recombinant enzymes. Amylose resin (New England Biolabs) was 
loaded onto a 5-mL self-packing column with a 45- to 90-μm-pore-size polyethylene 
filter (frit) (Life Science Products, Chestertown, MD, USA), and the resin was allowed to 
settle. The column was equilibrated with 5 column volumes of cold wash buffer (50 mM 
NaH2PO4, 150 mM NaCl, 1 mM DTT, 1 mM EDTA, pH 7.2). The soluble bacterial 
fraction was applied to the column and allowed to drain. The column was washed again 
with 5 column volumes of cold wash buffer. The recombinant proteins were eluted with 
the MBP moiety using elution buffer (wash buffer plus 10 mM maltose). The 
recombinant protein concentrations were determined by a NanoDrop spectrophotometer 
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(NanoDrop Technologies, Wilmington, DE, USA). Eluted proteins were resolved by 
SDS-PAGE (7.5% acrylamide) with Coomassie brilliant blue staining. 
UDP-GloTM and GDP-GloTM GT assays. Detection of free uridine diphosphate (UDP) 
after hydrolysis of the sugar nucleotide was performed using the UDP-GloTM GT assay 
kit (Promega Corporation, Madison, WI, USA), which detects UDP after UDP-sugar 
hydrolysis or transfer by converting UDP to light (measured in Relative Luminescence 
Units) in a luciferase-type reaction. Detection of free guanosine diphosphate (GDP) from 
GDP-sugar hydrolysis was evaluated using the GDP-GloTM GT assay kit (Promega 
Corporation), which operates by the same principles as above. A standard curve using 0–
25 μM of the respective nucleoside diphosphate (NDP) was performed, and the range of 
measurements was determined to be in the linear range of detection, where the 
luminescence detected is directly proportional to NDP concentration. Enzymes were 
diluted with an optimized GT solution (0.1 M MOPS-NaOH pH 7, 10 mM Mn2+) and 
supplemented with 100 μM of the targeted nucleotide sugar(s). Each sugar–nucleotide 
hydrolysis reaction was incubated at 16 °C for 16 h. Following the manufacturer’s 
protocol, each reaction was combined in a ratio of 1:1 (25 μL: 25 μL) with the UDP-
GloTM detection reagent in independent wells of a white, flat bottom 96-well assay plate 
and allowed to incubate at ambient temperature. After 1 h of incubation, luminescence 
was measured in triplicate, which is directly proportional to UDP or GDP concentration 
based on the standard curves. Luminescence measurements were performed with a 
VeritasTM microplate luminometer (Turner Biosystems, Sunnyvale, CA, USA) using a 
96-well microplate with standard 128 × 86-mm geometry with an integration time of 1.0 
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s. Luminescence was measured by a low-noise photomultiplier detector through an empty 
filter position in the emission filter wheel. 
4.2.B. Results and Discussion 
In silico analysis of A111/114R domain 1. PBCV-1 encoded protein A111/114R was 
annotated in NCBI (https://blast.ncbi.nlm.nih.gov/) as a hypothetical protein 
(NP_048459) of which only one region was predicted to be a GT (262 to 382 aa). PSI-
BLAST analysis [237] revealed that A111\114R was conserved among all chloroviruses 
with 62–94% sequence identity, reinforcing the notion that it could be involved in the 
assembly of the conserved oligosaccharide core. Therefore, to elucidate the function of 
A111\114R, we analyzed the full-protein sequence using HHpred tool [236], which 
predicted three putative GT domains. N-terminal homology with several known GTases 
(>98% probability) was identified for residues 1 to 256; hence, we assigned residues 1 to 
260 aa as domain 1 (A111/114R-D1). The other two domains are discussed in the 
following sections. 
Protein structure prediction by Phyre2 analysis [235] identified six GT crystal 
structures (Table S1 [234]) to model three-dimensional structures of A111/114R-D1 
based on 50–82% protein coverage (>90% confidence and 12–23% sequence identity). 
Models were ranked according to raw alignment score using the sequence and the 
secondary structure similarity, inserts, and deletions. Interestingly, the top ranked models 
were based on two xylosyltransferases (PDB:6BSV, 4WMA), one glucosyltransferase 
(PDB:1LL2), and three galactosyltransferases (PDB:1GA8, 5GVV, 6U4B), in agreement 
with our initial hypothesis, as both Xyl and Gal are part of the conserved region of the 
core glycan (Figure 1.10). The highest ranked model was the xylosyltransferase XXT1 
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from Arabidopsis (PDB: 6BSV) based on 120 residues (19% identity with 96% 
confidence). However, the homologous region of A111/114R-D1 (9 to 168 aa) that 
aligned with XXT1 residues 167 to 287 had no homology with the residues in the active 
site of the XXT1 model, which utilized Lys-382, Asp-317, Asp-318, and Gln-319 to bind 
the nucleotide sugar for catalytic activity [238]. Similarly, important residues for enzyme 
activity in the xylosyltransferase XXYLT1 (PDB: 4WMA) from Mus musculus [239] 
(His-262, Trp-265, and Gly-325) did not share homologous positions with A111/114R-
D1. Based on this evidence, we deduced that A111/114R-D1 has no xylosyltransferase 
activity, and for this reason we examined the other high top ranked models, all reporting 
well characterized galactosyltransferases (PDB: 1GA8, 5GVV, 6U4B), except for 1LL2 
which is a glucosyltransferase involved in glycogen synthesis [240]. Although 
glucosyltransferase activity cannot be definitely ruled out, A111/114R-D1 lacks the 
equivalent 1LL2 residue, Tyr-194, involved in Glc addition. 
In order to investigate possible galactosyltransferase activity for A111/114R-D1, 
we chose, as reference protein, LgtC (1GA8), a galactosyltransferase of Neisseria 
meningitidis, for which the residues involved in the sugar–nucleotide binding and in the 
catalysis were well characterized. LgtC is a retaining GT that transfers α-D-Gal from 
UDP-Gal to a terminal lactose. The structure of LgtC was solved in complex with Mn2+ 
and a non-cleavable analog of the donor sugar (UDP-Gal) in which the hydroxyl at the 2′ 
position of the Gal was substituted by a fluorine for stability purposes [241]. The 
alignment of the protein sequences of LgtC and A111/114R-D1 (Figure 4.2), along with 
the structural superimposition of the 3D model of A111/114R-D1 based on LgtC (Table 
S1 [234]) with 1GA8 (Chain A) in complex with Mn2+ and an analog of the donor sugar 
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(Figure 4.3), clearly revealed that all the residues responsible for binding and catalysis 
were preserved. In detail, A111/114R-D1 shares four sugar binding residues with LgtC, 
namely Asp-85, Asn-149, Asp-193, and Gln-194, which correspond to Asp-103, Asn-
153, Asp-188, and Gln-189 in LgtC (1GA8). Mutagenesis experiments have established 
that LgtC Gln-189, contained within the invariant D/EQD motif found in all members of 
GTases in family 8 (GT8), plays a crucial role in binding and probably in catalysis as 
well [241]. A catalytic mechanism leading to the retention of the anomeric carbon 
configuration for A111/114R-D1 is consistent with the presence in the oligosaccharide 
core of an α-D-Gal (Figure 1.10). It has also been proven that LgtC is a cation-dependent 
GT [241]. Indeed, LgtC exhibits the typical DXD motif (103DXD105), common in a wide 
range of GTases, both in prokaryotes and eukaryotes [242]. In addition, a crucial role has 
been attributed to Asp-103, as LgtC D103E and D103N mutants present a dramatic 





Figure 4.2. Amino acid sequence alignment of A111/114R domains and known 
GTases. Invariant and similar residues are highlighted in black and gray, respectively. 
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Sequences from the following organisms were used (PDB code) for three individual 
domains (D1, D2, and D3), respectively: (a) N. meningitidis LgtC galactosyltransferase 
(1GA8), (b) E. coli K4CP dual GalNAc-transferase and GlcA-transferase (2Z86), and (c) 
H. pylori fucosyltransferase (2NZW). Homologous residues positioned less than 4 Å 
from the nucleotide sugar in the three-dimensional model analysis are marked with an 
asterisk (*). Known residues from annotated enzymes that interact with the nucleotide 
sugar donor and ion are marked with a dot (•) and underline (−), respectively. Multiple 
alignment was performed by Phyre2 using structural information and homology 
extension. File output was compiled by BOXSHADE. 
 
However, the 103DXD105 motif of LgtC is not preserved in position with 
A111/114R-D1, except for LgtC Asp-103, which corresponds to A111/114R-D1 Asp-85. 
Homologous to residue LgtC Asp-103, Asp-85 of A111/114-D1 is positioned in close 
proximity to a divalent cation and to the nucleotide sugar, as denoted with the 
characteristic ligand distance < 4 A° (Table 4.1). It is likely that Asp-85 is sufficient in 
providing one side-chain oxygen ligand in coordination with Mn2+, as evident from the 
structural superimposition (Figure 4.3). The evidence that A111/114R-D1 possesses all 
residues involved in binding and catalysis is further supported by the fact that other well-
noted galactosyltransferases exhibit similar homologies. The GT GlyE from 
Streptococcus pneumoniae TIGR4 (PDB: 5GVV) binds UDP-Gal [243], and it shares the 
same conserved sugar binding residues as LgtC and A111/114R-D1 (Asp-103, Asn-142, 
Asp-177, and Gln-178) (Figure S2 [234]). Mutation of these key residues in GlyE 
completely abolished the hydrolytic activity [243]. Additionally, the bifunctional domain 
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polymerase WbbM from Klebsiella pneumoniae (PDB: 6U4B) possesses a C-terminal 
galactopyranosyltransferase [244] with similar homologous residues, Asp-486 and Gln-
487, resembling the known GT8 family enzyme signature likely to bind UDP-Gal. 
 
Table 4.1.  







Figure 4.3. Superpositions of A111/114R-D1, -D2, and -D3 with structural homologs. 
Individual domains of A111/114R (cyan) are shown independently as ribbon diagrams 
superimposed with known GTases (gray) bound to respective nucleotide sugars drawn as 
stick models (orange) and Mn2+ ion (magenta): N. meningitidis LgtC with UDP-
fluorogalactose (PDB: 1GA8), E. coli K4CP with UDP-glucuronic acid (PDB: 2Z86), 
and H. pylori fucosyltransferase with GDP-Fuc (PDB: 2NZY) are superposed with D1, 
D2, and D3, respectively (left to right). The corresponding active sites of D1, D2, and D3 
are shown magnified below the complexed stereoviews with labeled residues proposed to 
be involved in sugar and ion coordination. Hydrogen bonds are represented as yellow 
dotted lines. 
 
In silico analysis of A111/114R domain 2. Three-dimensional renderings of the central 
domain of A111/114R (261 to 559 aa), referred to as A111/114R-D2, were assembled 












Domain 1 Domain 2 Domain 3
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protein model predictions based on as high as 97% coverage with 100% confidence (11–
18% sequence identity) from multiple N-acetylgalactosaminyltransferases (Table S1 
[234]). The top ranked model was based on the second domain of the chondroitin 
polymerase K4CP from E. coli (PDB: 2Z86), namely 197 residues (66% of the protein 
sequence) of A111/114R-D2 were modelled with 100% confidence. K4CP is a bi-
functional enzyme organized into two GT-A domains (A1 and A2) that catalyzes 
elongation of the bacterial chondroitin chain [245]. K4CP A1 (1–417) and A2 (418–682), 
located respectively to the N- and C-terminal, are engaged in the transfer of GalNAc and 
GlcA residues alternatively from UDP-GalNAc and UDP-GlcA. The 3D model of 
A111/114R-D2 (261–474) is based on the second domain (A2) of K4CP (435 to 631 aa), 
which binds UDP-GlcA, thus excluding GalNAc-transferase activity. The GlcA, absent 
in the oligosaccharidic core, has the same stereochemistry of Xyl and differs from this 
monosaccharide by a carboxyl function attached to carbon 5. This finding suggests that 
the A111/114R-D2 could be a xylosyltransferase, and for that reason we used K4CP-A2 
as a reference to assess the conservation of the residues implicated in binding and in 
catalysis. Sequence alignment of A111/114R-D2 with K4CP-A2 validated the conserved 
residues involved with GlcA binding and divalent cation coordination (Figure 4.2). In 
detail, A111/114R-D2 residues involved in the sugar-nucleotide binding are Pro-265, 
Asp-294, and Asn-323, which correspond to Pro-439, Asp-469, and Asn-496 in K4CP-
A2 [245]. Superposition of K4CP Chain D with the predicted A111/114R-D2 structure 
(Figure 4.3) showcase these residues aligning in close proximity (<4 Å) to the nucleotide 
sugar (Table 4.1), strengthening their participation in sugar-binding and catalysis. K4CP, 
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in analogy with other GT-A fold GTases, has a 519DSD521 motif coordinating the Mn2+. 
This DXD motif is preserved in A111/114R-D2 and corresponds to 351DDD353. 
Together, the corresponding catalytic sites and DXD motif support orthology in 
enzyme activity. Of further note, two additional DXD motifs (Figure S1 [234]) are 
present downstream of A111/114R-D2 (422DRD424 and 439DPD441) that potentially could 
play an active role in substrate recognition or catalysis, but they do not exhibit homology 
with K4CP (Figure 4.2). Should A111/114R-D2 have functional xylosyltransferase 
activity, it would be the first xylosyltransferase sandwiched between two domains 
specific for different nucleotide sugars. The placement of the proximal Xyl in the core 
glycan structure, positioned closely to Gal and Fuc, is agreeable with the proposed 
domain organization of A111/114R. 
In silico analysis of A111/114R domain 3. The C-terminal domain (560 to 860 aa), 
referred to as A111/114R-D3, was clearly predicted as a putative α-1,3-fucosyltransferase 
(Table S1 [234]) modelled from Helicobacter pylori (PDB: 2NZW) with 100% 
confidence and 15% sequence identity (86% coverage). The prediction is that Fuc is 
linked to the O-3 of a Glc, which, like the monosaccharide contributions of domains D1 
and D2, is a component of the overall virus core glycan structure. Fucosyltransferase 
belongs to the GT B family, in which the protein contains N- and C-terminal domains 
binding to the acceptor and donor substrates, respectively. Normally, these GTases do not 
have a recognizable DXD motif responsible for the Mn2+/Mg2+ binding; however, 
A111/114R-D3 has a 642DLD644 signature (Figure S1 [234]) that must be evaluated for 
activity. A sequence alignment of A111/114R-D3 and H. pylori fucosyltransferase 
(hpFucT) revealed conserved residues involved in binding of the donor substrate, GDP-
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Fuc (Figure 4.2); Asn-240, Tyr-246, Glu-249, and Lys-250 correspond to Asn-749, Tyr-
755, Glu-758, and Lys-759 in A111/114R-D3, respectively (Table 4.1). Classified as an 
inverting GT, the proposed catalytic mechanism of hpFucT incorporates Glu-95 as a 
general base in catalysis, while Lys-250 and Arg-195 in hpFucT share a key role in the 
neutralization of the negative charged phosphate groups from GDP-Fuc to facilitate the 
glycosidic bond cleavage [246]. Glu-249 acts to stabilize in part the positive charge 
developed in the transition state as well as to form two hydrogen bonds with both the 
ribose and the Fuc residues of GDP-Fuc. The Glu-95 residue of hpFucT is located in the 
N-terminal domain, presumably associated with the acceptor substrate, and it has no 
equivalent in A111/114R-D3. This finding could be related to alternative acceptors in the 
two fucosyltransferase enzymes compared here, for example, hpFucT binding GlcNAc or 
A111/114R-D3 binding Glc. 
Comparison of superimposed proteins disclosed that the second half of 
A111/114R-D3 traces the C-terminal domain of hpFucT Chain A (160 to 320 aa), 
illustrating similarities in secondary structures. In contrast, structure resemblance 
decreases towards the N-terminal regions, which could be a result of different acceptor 
substrates. The open structure of the N-terminal region of the A111/114R-D3 model 
could be a consequence of a larger acceptor. 
To evaluate the sugar-binding and catalytic sites of A111/114R-D3, we 
superimposed the domain with hpFucT (Chain A) in complex with GDP-Fuc (PDB: 
2NZY). This overlap confirmed that all the expected residues involved in the GDP-Fuc 
binding were preserved and in good orientation (Figure 4.3), in agreement with the 
sequence alignment data (Figure 4.2). A111/114R-D3 residues Asn-749, Tyr-755, Glu-
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758, Lys-759 appeared <4 Å from the nucleotide sugar in agreement with their equivalent 
residues in hpFucT (Figure 4.3). This observation suggests these A111/114R-D3 residues 
likely participate in GDP-Fuc binding and are critical for A111/114R-D3 activity. 
Specifically, Asn-749, Tyr-755, and Glu-758 likely stabilize the positive charge on the 
Fuc moiety like their equivalent residue in hpFucT. Positioned close in proximity to 
GDP-Fuc is A111/114R-D3 residue Arg-693 that corresponds to Arg-195 in hpFucT, an 
essential residue for enzyme activity. In fact, Ala mutants of Arg-195 or Lys-250 resulted 
in no detectable activity, supporting the idea that the two residues provide positive 
charges to interact with negatively charged GDP-Fuc [246]. The important role of Arg-
693 is supported by its conservation amongst different chloroviruses. 
In vitro evidence of A111/114R hydrolytic activity. In order to test A111/114R for GT 
activity, we used the bioluminescent UDP/GDP-GloTM assays to detect free UDP/GDP 
released by GT-mediated hydrolysis of the nucleotide sugars. This allowed us to screen 
for nucleotide donor specificities without their target substrates (acceptor). A time course 
experiment with the full-length recombinant A111/114R protein in the presence of the 
core monosaccharides UDP-Gal, UDP-Xyl, GDP-Fuc, and Glc displayed evidence of 
UDP-hydrolysis (Figure 4.4). Glc was supplemented to simulate the Glc-Asn acceptor 
located on the nascent glycoprotein. The release of the UDP increased steadily over time, 
suggestive of GT activity by A111/114R-mediated hydrolysis. 
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Figure 4.4. A111/114R-catalyzed hydrolysis of UDP-sugars. Time-course experiment 
with the full-length recombinant A111/114R protein (6 µg) in the optimized buffer 
consisting of 0.1 M MOPS-NaOH (pH 7.0), 10 mM MgCl2, and 100 µM each of UDP-
Gal, UDP-Xyl, GDP-Fuc, and Glc for 16 h at 16 °C. The release of UDP was detected by 
the UDP-GloTM assay. Data are representative from three independent replicates, and 
error bars represent standard deviation. 
 
We recombinantly expressed the full-length A111/114R protein (1 to 860 aa) and 
three variants with omitted regions (Figures 4.5a and 4.5b). A111/114R (1–397 aa) 
contains the complete domain 1 and approximately the first half of domain 2, A111/114R 
(266–860 aa) contains the complete domains 2 and 3, and A111/114R (391–860 aa) 
contains the second half of domain 2 and the complete domain 3. Constructs containing 
only individual domains were originally designed; however, their proteins did not exhibit 
activity. This may reflect inaccurate residue boundaries or an incorrect folding of the 
single domains in the absence of adjacent ones. Representative data from each assay are 
 137 
shown in Figure 4.5 (4.5c and 4.5d) and are represented as a ratio of the UDP or GDP 
measured from reactions containing the indicated GTases relative to the full-length 









Figure 4.5. Hydrolysis of UDP- and GDP-sugars by A111/114R and truncated 
constructs. (a) SDS-PAGE analysis of the expressed proteins: full length recombinant 
MBP-A111/114R (144 kDa), and truncated variants MBP-A111/114R (1–397) (87 kDa), 
MBP-A111/114R (266–860) (110 kDa), and MBP-A111/114R (391–860) (96 kDa) were 
eluted from an amylose column and resolved by SDS/PAGE with Coomassie blue 




























separated on a 4–20% tris-glycine gel. (b) Cartoon renderings of the full-length 
A111/114R protein and truncated versions are color coordinated by three putative 
domains (D1, D2, D3), each corresponding to a different nucleotide sugar donor. White 
regions denote omitted sections of A111/114R. Shortened constructs are defined by their 
residues in the left column. (c and d) Representative data from hydrolysis assays shown 
as a ratio of the UDP (c) or GDP (d) measured from reactions containing the indicated 
GTases relative to the negative controls where no enzyme was added. The release of 
UDP and GDP was detected by the UDP-GloTM assay and GDP-GloTM assay, 
respectively. GDP-hydrolysis from GDP-Fuc was significantly elevated in the presence 
of UDP-Gal and UDP-Xyl with A111/114R (266–860) and A111/114R (391–860). Data 
are representative from three replicates, and error bars represent standard deviation. 
 
Analysis of UDP/GDP-hydrolysis by the A111/114R constructs reported in 
Figure 4.5b were especially revealing in regard to A111/114R domain assignments. 
Indeed, starting with the A111/114R (1–397) construct, the UDP molecules were 
detected only when UDP-Gal was used (Figure 4.5c). Given A111/114R-D2 is half 
omitted in A111/114R (1–397), hydrolysis of UDP-Gal implies A111/114R-D1 is a 
galactosyltransferase. In agreement, no UDP was produced from UDP-Gal containing 
reactions involving A111/114R constructs devoid of the first domain, A111/114R (266–
860) or A111/114R (391–860). This finding is in agreement with the bioinformatic data. 
Hydrolysis of UDP-Xyl by A111/114R (266–860) suggests either A111/114R-D2 
or A111/114R-D3 has xylosyltransferase activity. However, UDP-Xyl was not detected 
in reactions involving A111/114R (1–397) or A111/114R (391–860), both of which are 
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devoid of a complete D2 (Figure 4.5b). This suggests that A111/114R-D2 (260–560) 
harbors the xylosyltransferase activity. GDP-Fuc hydrolysis was detected in reactions 
involving A111/114R (266–860) and A111/114R (391–860) exclusively (Figure 4.5d). 
These results suggest A111/114R-D3 is a fucosyltransferase. Notably, GDP-Fuc 
reactions supplemented with UDP-Gal and UDP-Xyl showed elevated levels of liberated 
GDP, especially in the presence of A111/114R (266–860). This could be a result of 
improved protein folding allowed by the extension of residues and co-presence of the 
nucleotide sugars. 
Finally, to evaluate the residues of A111/114R involved in hydrolytic activity, we 
constructed Ala mutants by site-directed mutagenesis (SDM) (GenScript) to target amino 
acids from each domain predicted to be involved in nucleotide–sugar or metal–ion 
binding. Three mutants were expressed, each containing two Ala substitutions inside 
separate domains. A111/114R-D1, -D2, and -D3 SDM constructs contained Ala mutants 
of Asp-85 and Gln-194, Asp-351 and Asp-353, and Arg-693 and Lys-759, respectively. 
In the presence of UDP-Xyl, UDP-Gal, GDP-Fuc, and Glc, the SDM of D1, D2, and D3 
resulted in a significant reduction in UDP-sugar hydrolysis, lowering the activity by 95%, 
90%, and 80%, respectively (Figure S3 [234]). Likewise, in the presence of the same 
nucleotide–sugars, GDP-Fuc hydrolysis was reduced by 90%, 70%, and 96%, 
respectively. This dramatic reduction in detectable nucleotide–sugar hydrolysis supports 
the idea that these residues are critical for enzyme activity, and that A111/114R functions 
best when all three domains are active. 
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4.2.C. Conclusions 
The giant chloroviruses continue to challenge our understanding of canonical 
metabolic pathways in host–virus interplay. The identification of the atypical N-glycan 
structure attached to the PBCV-1 Vp54 has led to the characterization of virus-encoded 
enzymes involved in glycosylation independent of host-derived ER and Golgi GTases. 
The N-glycan’s core pentasaccharide conserved among the chloroviruses is especially 
noteworthy and prompted us to investigate candidate virus-encoded GTases involved in 
the assemblage of part or all the conserved core oligosaccharide. Results in this study 
establish that PBCV-1 encoded protein A111/114R has three GT domains of 
approximately 300 aa each. Evidence from a combination of amino acid alignments, three 
dimensional renderings, and GT assays indicate that the N-terminal (1 to 260 aa), central 
(261 to 559 aa), and the C-terminal (560 to 860 aa) regions resemble a 
galactosyltransferase, a xylosyltransferase, and a fucosyltransferase, respectively. The 
three-dimensional protein models built by Phyre2 are predictions and were used only for 
the purpose of identifying potential individual domains. As with all methods for protein 
modeling prediction, caution should be exercised when evaluating structural elements of 
new enzymes that lack homology to currently deposited structures in the Protein Data 
Bank archives. In fact, since the percent identity between the various domains and the 
structures on which they were modeled was low, it was not possible to model the various 
domains accurately. Eventually individual protein domains must be solved by 
biochemical and crystallographic methods to fully reveal their catalytic mechanism. 
Preliminary evidence suggests that A111/114R-D2 has xylosyltransferase activity 
and, if biochemically confirmed, presents a new structural class of xylosyltransferases 
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based on its limited resemblance to known xylosyltransferases. Moreover, A111/114R 
would be the second three-domain protein encoded by PBCV-1 that is involved in glycan 
synthesis. Indeed, recent studies showed that PBCV-1 protein A064R (638 aa) has three 
functional domains; the first two are GTases (β-L-rhamnosyltransferase and α-L-
rhamnosyltransferase, respectively) and the third is a MT that methylates O-2 of the 
terminal α-L-Rha residue [247]. 
It is known that many of the chlorovirus genes encode enzymes involved in 
various aspects of carbohydrate metabolism. However, it remains unclear how the virus-
encoded proteins are involved in the synthesis and/or assembly of the Vp54 glycan. For 
example, are the sugars added to Vp54 sequentially or are they synthesized independently 
of Vp54, possibly on a lipid carrier, and then attached to the protein en bloc? A slight 
variation of these two possibilities is to synthesize a core glycan(s) independently of the 
protein and attach it to Vp54. Additional experiments will be required to address this 
issue. 
Importantly, the results described herein provide support that the synthesis of the 
PBCV-1 core glycan structure, or at least part of it, is accomplished with a multidomain 
enzyme encoded by the virus itself. This finding is in line with the finding that another 
GT of PBCV-1, the protein A064R, is able to elongate the viral glycan with two units of 
Rha and to methylate the ultimate unit at O-2. Taking these finding together, the dogma 
that all viruses use host enzymes to glycosylate their proteins is further subverted. 
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CHAPTER V 
CONCLUSIONS AND FUTURE PROSPECTS 
5.1. OVERVIEW 
All living cells in all domains of life are covered in glycans, typically as 
glycoproteins and glycolipids. Glycans play diverse roles, including critical functions in 
the areas of cell signaling, molecular recognition, immunity, and inflammation. Here, we 
investigated the potential involvement of chlorovirus-encoded putative GTases and 
MTases in glycosylation of the viral MCP. First, we aimed to generate site-directed virus 
mutants by targeting associated viral genes. However, at present a significant barrier to 
genetic transformation in chloroviruses is the recalcitrance of its host green alga making 
reverse genetic manipulation of chlorovirus genomes not possible. To address these 
limitations, we tested popular transformation methods using cell wall-degrading 
enzymes, electroporation, SiC whiskers, cell-penetrating peptides, and Agrobacterium to 
generate GT-gene mutations in the chlorovirus CA-4B. We successfully delivered 
preassembled Cas9 protein-sgRNA ribonucleoproteins (RNPs) to macerozyme-treated 
NC64A cells that resulted in a frameshift mutation in the CA-4B-encoded gene 034r, a 
homolog of PBCV-1 GT gene a064r. Unable to duplicate these results, we shifted our 
focus to characterize PBCV-1-encoded proteins involved in glycan synthesis. 
We aimed to characterize chlorovirus-encoded proteins related to the synthesis of 
the unusual glycans attached to the MCP of PBCV-1. Our goal was to biochemically 
corroborate the involvement of virus-encoded GTases with the monosaccharides that 
comprise the atypical viral N-glycans. Specifically, we tested the functional properties of 
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undetermined virus-encoded proteins that are predicted to be involved in the synthesis of 
its N-glycan(s) as disclosed by bioinformatic analyses. We showed that A064R has three 
functional domains: domain 1 is a β-L-rhamnosyltransferase; domain 2 is an α-L-
rhamnosyltransferase, and domain 3 is a MT that methylates the C-2 hydroxyl group of 
the terminal α-L-Rha unit. We also established that methylation of the C-3 hydroxyl 
group of the terminal α-L-Rha is achieved by another virus-encoded protein, A061L 
which acts on the substrate, only if the methyl group on O-2 is already installed. 
Moreover, genetic and structural analyses indicated the protein coded by PBCV-1 
gene a111/114r, conserved in all chloroviruses, is a likely a GT with three putative 
domains: domain 1 is a galactosyltransferase, domain 2 is a xylosyltransferase, and 
domain 3 is a fucosyltransferase. Hydrolytic assays supported these predictions 
suggesting that A111/114R is likely responsible for the attachment of three of the five 
conserved residues of the core region of this complex glycan. These findings provide 
additional support that the chloroviruses do not use the canonical host ER-Golgi 
glycosylation pathway to glycosylate their glycoproteins; instead, they perform 
glycosylation independent of cellular organelles using virus-encoded enzymes. 
The unusual chlorovirus N-glycan structure(s) is synthesized by enzymes encoded 
by the virus and does not involve the host glycosylation machinery. That is, unlike most 
other viruses, the prototype chlorovirus PBCV-1 encodes most, if not all, of the 
machinery required to glycosylate its MCP in the cytoplasm rather than in the ER and 
Golgi that is typical for most glycoprotein-containing viruses that use host enzymes to 
synthesize their glycans. This finding is particularly relevant as it challenges the dogma 
that all viruses use host enzymes to glycosylate their proteins. If our predictions about 
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chloroviruses are correct, investigations of these organisms will provide the field of 
glycobiology with new discoveries and may ultimately answer the central question about 
what benefits these viruses have by maintaining their own glycosylation machinery 
through evolution. These findings could suggest an alternative virus-encoded 
glycosylation pathway that perhaps pre-dates the evolution of the canonical Golgi-ER 
glycosylation pathway. 
Historically, GTases from eukaryotic organisms have been difficult to study 
biochemically and structurally because they are membrane associated, notoriously 
unstable, often contain flexible loops and domains and are commonly associated with 
other interacting proteins. In contrast, as described here, GTases encoded by a group of 
viruses, called chloroviruses, lack transmembrane domains because they function in the 
cytoplasm of their host algae. Consequently, their recombinant proteins are soluble and 
easy to work with biochemically. Our work has assisted in identifying and characterizing 
many of these novel chlorovirus-encoded GTases as well as virus encoded MTases (and 
possibly other modifications) that add methyl groups to specific sites on sugar molecules. 
Chlorovirus-encoded GTases and MTases contribute towards the expanding repertoire of 
enzymes for producing glycoconjugates that can be used in glycotechnological 
applications, e.g., for creating adjuvants for vaccines, creating novel biosurfactants and 
novel antibiotics. Finally, we suspect that some of the other giant viruses that are being 
discovered also probably encode unique GTases. If this proves true, giant viruses will 
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